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Chapter 1 
GENERAL INTRODUCTION 
based on: 
JJ.M.C.H. de la Rosette and F.M.J. Debruyne: Diagnostics and treatment of prostatitis: an 
actualized overview. 
Revue médicale de la suisse romande 1992; 112:757. 
J.J.M.С.H. de la Rosette and F.M.J. Debruyne: Nonbacterial prostatitis: A comprehensive 
review. 
Urol Int 1991 ;46:121. 
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INTRODUCTION 
The term "prostatitis" denotes a condition of inflammation of the prostate. 
Prostatitis is usually employed to describe any unexplained symptom or condition 
that might possibly emanate from a disorder of the prostate gland. The typical 
presentation includes complaints of pain in the perineum, suprapubic area, the 
lower back, testicles, groin, the flank and on ejaculation. Urinary symptoms include 
urgency, frequency, dysuria, urethral discomfort and hematospermia. Often com-
plaints are vague and on examination the prostate in most cases found to be 
normal in size, shape and consistency and there is minimal tenderness. 
The first formal discription of prostatitis appeared in 1857 in Sir Henry Thomp-
son's Diseases of the Prostate [1] and since that time a steady supply of articles on 
the subject has appeared in the literature. The gonococcus was undoubtedly the 
most common causative organism [2] until the work of Notthaft [3] noted increa-
sing difficulty in isolating Neisseria gonorrhoeae with increasing chromcity of the 
disease. The gonococcus now only accounts for the rare cases. Researchers were 
aware at an early stage of the difficulty in the collection and interpretation of 
specimens from the prostate. A variety of sampling techniques were employed, 
including irrigation of the urethra with antiseptics [4,5] and the use of elaborate 
endoscopes [6], and as a result more interest was taken in the role of aerobic and 
anaerobic bacteria such as the staphylococci, streptococci and cohform bacteria [5-
10]. A great break through was made by Stamey et al. by indicating the value of 
segmenting the voided bladder urine into three aliquote namely, first void (VB1), 
mid stream (VB2) and post-prostatic massage urine (VB3), enabling differentiation 
between urethral and prostatic infection in the presence of sterile mid-stream urine 
(figure 1) On the basis of these localization techniques, the various forms of 
prostatitis have been categorised into a practical classification [11] which broadly 
separates patients in terms of their aetiology. However, confusion still exists and 
prostatitis continues to have a bad reputation primarily due to imprecise methods of 
diagnosis. 
CLASSIFICATION 
On the basis of localization studies patients with prostatitis seperate into four 
groups: acute bacterial prostatitis, chronic bacterial prostatitis, non-bacterial 
prostatitis and prostatodynia (figure 2). The patients are categorised according to 
the microbiological findings in both the urine and expressed prostatic secretion. The 
acute bacterial and chronic bacterial prostatitis forms are distinguished easily. 
Those with an inflammatory reaction but no obvious infective aetiology suffer from 
non-bacterial prostatitis and in prostatodynia no inflammatory disease of the 
prostate is found. It is impossible on clinical grounds alone to differentiate between 
these groups as their symptoms of perigenital pain, irritative voiding and voiding-
dysfunction, are broadly similar. Because of the difficulty of identifying the aetiolo-
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gical factors involved in non-bacterial prostatitis and prostatodynia, and conse-
quently the difficulty of treatment in these patients, we will focus on these two 
subtypes. 
INCIDENCE OF PROSTATITIS 
It is difficult to ascertain the absolute incidence of prostatitis in the general 
population. However, Stamey [121 has estimated the relative incidence of the 
various forms of prostatitis in current urologie practice. Based on clinical experience 
he states that the incidence of nonbacterial prostatitis is much higher than the 
incidence of bacterial prostatitis. He estimated that about 50% of men will expe-
rience prostatic symptoms at some time during adult life [13]. Another study 
showed that there were 19 office visits for prostatitis annually per 1000 men for 
urological problems [14]. 
In one large clinic devoted to the care of men with inflammatory prostatic 
symptomatology, 5% of 597 patients were found to have chronic bacterial prostati-
tis, 64% apparently had nonbacterial prostatitis and 3 1 % had prostatodynia [15]. 
A review of autopsy studies by Moore [16], who examined 581 prostates from 
unselected autopsies of men aged 20-90 years, found that 6.3% of the prostates 
had histologic evidence of inflammation. He also noted that the incidence increased 
with age. An autopsy study by McNeal [17] showed that prostatitis is a common 
finding, its incidence increases with age and it is usually a focal process. 
AETIOLOGY 
Animal studies: Bacterial prostatitis is a common cause of urinary tract infection 
in males, but little is known of its aetiology. To study this, Neal et al. [18] develo-
ped a nonhuman primate model: monkeys had a urethral inoculation of Escherichia 
coli. They were followed with urine, blood and semencultures. When they were 
sacrified, their genitourinary tracts were histologically examined. The prostatitis 
paralleled that reported in humans and from this they concluded that the infection 
occurs by the ascending route. Jantos et al. [19] described another animal model. 
They inoculated Escherischia coli into the bladder of Mastomys natalensis, causing 
severe prostatitis. The histologic and microbiologic course of the prostatic infection 
resembeled strongly the human disease. Acute bacterial prostatitis was followed by 
the development of chronic bacterial or nonbacterial prostatitis. Prostatitis was 
observed histologically in all animals sacrified six months postinfection. Nickel et al. 
[20] studied the pathogenesis of chronic bacterial prostatitis in a rat model using 
Escherichia coli. Chronic bacterial prostatitis in this model was associated with 
sparse glycocahx enclosed protected bacterial microcolonies within the prostatic 
acini and ducts which appeared to stimulate a persistent local and systemic 
reaction resulting in chronic inflammation of the gland. 
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From these studies we can conclude that: 1. bacterial prostatitis may be caused 
by the ascending and descending route, 2. acute bacterial prostatitis may result in 
chronic bacterial or nonbacterial prostatitis and, 3. histological changes in the 
prostate can be found a long period postinfection 
Non-bacterial prostatitis: The factors and organisms contributing to nonbacterial 
prostatitis are confusing, contradictory and poorly defined. Earliest descriptions of 
prostatitis laid blame for the condition on a variety of causes, namely posterior 
urethritis, excessive sexual activity and bicycle riding [21]. Later work considered 
the possibility of ascending infection from the urethra, but also felt foci of sepsis, 
such as infected teeth and sinuses were contributory [22]. However until now 
searchers have failed to find any real aetiological organisms [23,24]. Infectious 
aetiologies have been the most widely studied. The possibility that clinically 
undetectable infections by gram negative bacteria or enterococcus may be operati-
ve is inconsistent with existing knowledge concerning the nature of bacterial 
prostatitis and its favorable symptomatic response to suppressive antimicrobial 
therapy. Infection by microorganisms that are difficult to identify, such as fungi, 
obligate anaerobic bacteria, trichomonands, and viral agents have been eliminated 
as common causes of the disorder. Attention has also focused on the possible role 
of Chlamydia trachomatis and Ureaplasma urealyticum as a cause of prostatitis 
[15,25] 
Failure to differentiate between urethritis and prostatitis may account for 
uncertainties regarding the role of C. trachomatis and U. urealyticum in the 
pathogenesis of nonbacterial prostatitis [26]. Some authors suggest that C. 
trachomatis may be involved in an inflammatory process engaging the prostate as a 
complication of urethritis [27]. At least C. trachomatis must be considered a 
possible etiologic agent of urethral symptoms. The possibility that Chlamydia 
trachomatis organisms might be involved was first raised on the basis of serological 
analysis [28-30] The role of chlamydiae was given further support by the isolation 
of organisms from the prostate of 33% of patients after blind transrectal prostatic 
aspiration biopsy [21]. Subsequent studies have been unable to corroborate these 
conclusions [31-34], though support has been forthcoming form Weidner et al. [35] 
who felt Chlamydia trachomatis and Ureaplasma urealyticum must be considered as 
aetiological agents in non-bacterial prostatitis. Inflammation mediated by prosta-
glandin [14], (auto)immunity [36-40] and allergic phenomenon [41] have each been 
implicated. Reflux of urine into the prostatic ducts has been proposed as a possible 
cause for symptomatic prostatic inflammation [42]. Others suppose that slow 
liquefying semen contributes to some extent to the complaints [43]. Several studies 
attempted to isolate aerobes, anaerobes, mycoplasma, fungi and viruses from the 
exprímate of the prostate and were unable to detect differences between the study 
and control group [23,24]. From these data we may conclude that none of the 
organisms studied causes the majority of the cases of nonbacterial prostatitis and 
that either an agent as yet unidentified or multiple agents be involved in the 
aetiology of nonbacterial prostatitis. Finally, some authors [44,45] even suggested 
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that chronic nonbacterial prostatitis may be a non-organismal inflammatory process 
Prostatodynia: There is no objective evidence of prostatic inflammation among 
patients with prostatodynia Research concerning the origin of this disorder has 
been directed towards illumination of extra-prostatic aetiologies Although the 
actual cause of most cases of prostatodynia remains unclear, urodynamic testing 
has frequently shown functional disorders of the lower urinary tract disorders of 
the bladder outlet [46], detrusor hyperreflexia and nonrelaxmg pelvic floor striated 
musculature [47] and pelvic floor tension myalgia due to habitai contraction and 
spasm [48]. 
Also psychological factors have been considered of playing an important role in 
the aetiology of chronic prostatitis In 1934, Mennmger has already proposed that 
personality traits are at issue in chronic prostatitis [49] and Lewin suggested in 
1960 that "psychological factors are suspected of playing an important role in the 
symptomatology of chronic prostatites and possibly in its aetiology"[50] The 
theoretical framework most often used in the research in prostatitis patients has a 
strong psychoanalytical basis, and the body of empencal evidence often suggests 
that a failure to respond to any given treatment for chronic prostatitis is apparently 
the result of abnormally high psychosomatic or psycho-neurotic conditions in these 
patients [51-53]. However the seperation of psychological factors from physical 
ones in any chronic disease is difficult, prostatitis being no exception, and further 
studies are needed to clarify the situation. 
RESULTS OF DIAGNOSTIC PROCEDURES 
A detailed analysis of the character and duration of the symptomatology, the 
results of prior investigations and the response to past treatments are critical 
components of the history Complete physical examination should be performed. 
Palpation of the prostate usually provides little insight into the nature of the chronic 
prostatitis syndrome 
Localization studies: In order to make a diagnosis of prostatitis, prostatic localiza-
tion studies are mandatory. These studies estimate the contribution of urethral, 
prostatic and bladder organisms to bacteriuna in specimen of voided urine from 
male patients. Examination of prostatic fluid in a microscopic counting chamber 
revealed that normal men had less than 10 WBC/HPF [13,54-56] Clinically 
significant prostatic inflammation is present when the WBC/HPF exceeds this limit 
Lipid-laden macrophages (oval fat bodies) are usually absent in normal prostatic 
fluid However, they are present in significant numbers in inflammation of the 
prostate and 1 - 2 lipid-laden macrophages/HPF implies prostatic inflammation. But 
the number of macrophages in the prostatic fluid bears little relation to the clinical 
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picture in prostatitis [57]. 
The lower tract localization studies, developed by Meares and Stamey [11] esti-
mate the contribution of urethral, prostatic and bladder organisms to bacteriuna in 
specimens of voided urine from male patients. Only 5-10% of patients are found to 
have a bacterial infection. The majority, (90%), seems to suffer from a disease, 
related to the prostate but no significant bacteria can be cultured form their prosta-
tic fluid. 60% of these patients are believed to suffer from non-bacterial prostatitis 
because the prostatic fluid reveals an elevated leucocyte count, although the search 
yields no causative agent. In the remaining patients, no signs of infection are found, 
and this condition is denoted prostatodynia. 
Semencultures: For the diagnosis of prostatitis, the 4-glas test is used. However, 
this test is rarely used by clinicians, because it has a low sensitivity, its interpretati-
on criteria are, as yet, not unambigiously defined, it taxes the patients, is time 
consuming and is relatively expensive. Therefore many clinicians prefer to perform 
semencultures instead of the 4-glass test. Christiansen and Purvis, reported that no 
difference was found between the results of a bacterial culture using Stamey's 4-
glass method or aliquotes of the ejaculate [58]. These findings are in conflict with 
the results from Eijsten et al. who stated that bacteriologie tests of the ejaculate do 
not yield as reliable results as the four-glass test [59]. Therefore we may conclude 
that the value of semencultures seems limited and can only be used additionaly to 
the four-glass test. 
Ultrasound of the prostate: Because the majority of patients with prostatic 
complaints have no clinical evidence of an inflammatory process within their 
prostates or lower urinary tract, other methods are needed to differentiate this 
group of patients with so-called prostatitis. However, still to be established as a 
decisive method in the diagnosis prostatitis, prostatic ultrasound can be supposed 
to offer a substantial contribution. To be of potential value, it should give urologists 
additional information that cannot be obtained by conventional methods. 
In several studies, specific ultrasonographic characteristics in patients with 
prostatitis have been described [60,61]. The characteristic ultrasonographic pat-
terns obtained, consisted of dyshomogeneous echo structure of the prostate, 
constant dilatation of the periprostatic venous plexus, dilated elongated seminal 
vesicles with thickening of the inner septa, and bladder neck hypertrophy. Prostatic 
lithiasis were a relatively common finding but no pattern of prostatic calcification is 
associated typically with chronic prostatitis [62]. Also nonspecific echogenic 
qualities in prostatitis have been pointed out [62,63]. Therefor we may conclude 
that at the moment, the potential value of prostate imaging in the diagnosis of 
inflammatory disorders of the prostate is largely unexplored. At present, prostate 
imaging is not recommended in the routine evaluation of men with prostatitis. 
Perhaps new techniques, such as computer assited image analysis, may give 
additional information. 
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Immunology: The lower urogenital tract of the male has a variety of defenses 
against infection. These defenses consist of nonspecific mechanisms, such as 
mechanical factors (urethral length, micturition, ejaculation) and antimicrobial 
secretions. They also include the humoral and cellular defense. The crucial role of 
the immune system in the defense against infection and its intimate involvement in 
the pathogenesis of a wide variety of chronic diseases is well established. Howe-
ver, our knowledge of the distribution of the cells of the immune system in the 
human prostate is limited. Several studies suggest that patients with prostatitis 
may be forming increased concentrations of immunoglobulins to antigens which are 
yet unidentified or unrecognized [25]. El-Demiry et al. defined the anatomical 
location and distribution of immune-competent cells within the tissue of the 
prostate. These studies have revealed a consistent pattern of the distribution of 
immune-competent cells within the tissue of the prostate [37]. Another immunolo-
gical study revealed that true bacterial prostatitis can be clearly distinguished 
immunologically from non-bacterial prostatitis on the basis of the local IgA response 
in the prostatic fluid. Therefore, immunological analysis can provide a sensitive test 
for distinguishing between bacterial and non-bacterial prostatitis [64]. However in 
general practice they are not frequently used. 
Urinecytology: Although the term "prostatitis" implies an infectious disease, 
serious doubt exists as to the infectious origin of the condition in some cases. 
Interstitial cytstitis, carcinoma-in-situ or invasive bladder tumors may give similar 
complaints as prostatitis, and should be ruled out with cytology of the urine and 
cystoscopy. If necessary a bladder biopsy and an IVU should be performed. 
Although recommended in literature, no exact data are available concerning the 
value of urine cytology in the screening of patients with prostatitis. 
Uroflowmetry: Typical complaints of patients with prostatitis are pain and 
micturition complaints. Uroflowmetry abnormalities, as for example poor flow, are 
reported in 30% of cases [65]. Research concerning the origin of this disorder has 
been directed towards the illumination of extra-prostatic aetiologies and urodynamic 
testing has frequently shown functional disorders of the lower urinary tract [46-48]. 
Awad and Downie were among the first who presented the results of treatment 
using alpha blockers in these patients with urodynamic abnormalities [66]. Other 
authors confirmed this favorable effect, caused by an alpha-receptor blockade, in 
patients with bladder neck dysfunction [67,68] and Osborn et al. stated that 
patients with prostatodynia and urodynamic abnormalities should be treated with 
alpha-blockers [69]. 
Radiodiagnostics: Osteitis pubis or urolithiasis may also resemble prostatitis and 
for this reason a radiographic screening is advised [70]. However little is known of 
the value of routine radiodiagnostic work up in patients with prostatitis syndromes. 
In case of flank pain, pain in the groin, pain in the suprapubic area or suspicion of 
urogenital abnormalities, one may perform a plain abdomen X-ray and/or ultrasound 
General introduction 15 
of the kidneys. Furthermore, an IVU should only be performed if abnormalities are 
found on a plain abdomen X-ray, ultrasound of the kidneys or in case of haematu-
ria. 
Psychological tests: In general, urology patients as a group tend to exhibit a wide 
spectrum of psychiatric problems [71]. Among urologists there is a widely held 
belief, that especially "neurotic" patients have many complaints in the genito-
urinary region. Thus, a failure to respond to any given treatment for chronic 
prostatitis may possibly be the result of psychosomatic or psycho-neurotic conditi-
ons in these patients. The major portion of research often used qualitative tests 
(Rorschach, Minnesota Multiphasic Personality Inventory, Thematic Apperception 
Test, Beck's Depression Inventory) and have interpretated results predominantly 
from a psychoanalytical perspective. The three themes which consistently surface 
in these investigations of potential causes of chronic prostatitis are neuroticism, 
psychosomaticism and sexual problems [51-53]. 
Figure 3 
Evaluation of prostatitis syndromes - overall conceptual approach 
symptoms 
inflammation of micturition 
the prostate disturbances 
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TREATMENT 
The most appropriate therapeutic remedy for prostatitis has yet to be discovered, 
though many patients with acute and chronic bacterial prostatitis will gain relief 
from their symptoms, although in the case of the latter group, relapse is common-
place Greenberg et al. found that the aetiologic agent of chronic prostatitis could 
not be identified in 83% of the cases [72]. When it could be identified, Steptococ-
cus faecahs, Enterobactenaceae, and pseudomonads were the most frequent 
pathogens [13,73,74]. These patients should be treated with an antibiotic that 
achieves adequate prostatic concentrations, such as trimethoprim, doxycychne or 
quinolones [751. Despite a prolonged (6-12 weeks) administration of these agents, 
failure to eradicate bacterial prostatitis is usually 30% to 40% [75,76]. The 
greatest problem lies in the management of non-bacterial prostatitis and prostatody-
nia, mainly due to the limited knowledge of its aetiology. 
Non-bacterial prostatitis: Since the cause of nonbacterial prostatitis is unknown, 
definitive therapy is difficult Antimicrobial therapy is the most frequent advocated 
treatment in patients with prostatitis. Available evidence suggests that some 
patients with nonbacterial prostatitis will also improve with antimicrobial therapy 
[15,77,78]. The drugs of first choice are trimethoprim-sulfamethoxazole and 
tetracycline hydrochloride. These drugs are as effective as the newly introduced 
quinolones but less expensive. The antimicrobial therapy should be administered 
during a period of at least 6 weeks. If this treatment is effective and the patient 
complains of recurrence, prophylactic low-dose continuous antimicrobial therapy 
should be administered to prevent reccurence. Unless the response is favorable, 
further use of antimicrobial agents is seldom warranted But in the absence of 
established treatment for chronic nonbacterial prostatitis, it is suggested that the 
antimicrobial therapy is worth consideration [77]. Several studies indicate a possible 
role of the U urealyticum in prostatitis [15,79]. Speculations also continue 
regarding the possible role of C. trachomatis as a causative agent [80]. If the 
clinician suspects infection caused by either one of them, a clinical trial during a 
period of 6 weeks with tetracyclic preparations, is a reasonable approach in initial 
treatment [81] If the response to antimicrobial treatment is unsatisfactory, 
treatment should be directed toward controlling the symptoms. Some patients need 
dietary restrictions (no alcohol or spicy food) and the liberal use of hot sitz baths is 
quite beneficial. Episodes of acute symptoms are often alleviated by short-term use 
of muscle relaxants, anticholinergic drugs or anti-inflammatory drugs. Additionally, 
the effects of sodium pentosanpolysulphate on symptoms related to nonbacterial 
prostatitis have been evaluated [82]. A beneficial effect was registered from 
muscles and joints, lasting for a few months after the end of the medication. The 
benefit of therapeutic prostatic massage advocated by many is questionable as well 
as diathermy in the treatment of patients complaining of nonbacterial prostatitis 
Surgical treatment is another option in the treatment of nonbacterial prostatitis. 
Stamey [12] reported a 33 % cure of chronic bacterial prostatitis by transurethral 
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resection. Until now, no studies on the effect of surgical treatment of nonbacterial 
prostatitis have been performed. Nevertheless, for some patients who require a 
prostatectomy for other reasons than their recurrent infection, a transurethral 
resection may be warranted. 
Psychologic factors may be important etiologically in chronic nonbacterial 
prostatitis and most patients benefit considerably from a frank discussion of the 
nature of the condition. The clinician should take time to fully explain the syndrome 
to the patient. He should also explain that nonbacterial prostatitis will likely cause 
intermittent symptoms, will seldom disappear permanently and that the condition 
does not lead to cancer or other serious diseases elsewhere in the body. Some 
studies suggest that hormonal imbalance contributes to the pathogenesis of 
nonbacterial prostatitis [83]. Studies about the benefit of hormonal treatment have 
been performed in man and animal. McKenzie et al. [84] performed castration in 
dogs. After castration all prostates were more or less uniformly atrophied, the 
atrophy being confined to the epithelial element. The cells had a washed out 
appearance. Testosterone administration prevented this atrophy to a degree 
commensurate with the dose administered. Smith and Gardner [85] suggested that 
elevated estrogen levels in the prostate may stimulate increased stromal synthesis 
by altering the collagen metabolism of the organ, thereby leading to a chronic 
inflammatory state. After treating rats with 17 В estradiol the incidence of prostati­
tis markedly increased from 27% to 100%. Androgens were able to block the 
effect of estradiol on prostatitis. Neither antiestrogens nor aromatose inhibitors 
(blockage of conversion of testosterone to estradiol) altered the incidence of 
spontaneous prostatitis. These findings suggest that testosterone has a direct 
effect in the rat prostate which protects against prostatitis. Lundgren et al. [86] 
reported a reduction of the inflammatory reactions in the treatment of rat prostatitis 
with methylprednisone and testosterone ester. These results also suggest the 
possibility of using androgens (or corticosteroids) for the treatment of patients with 
prostatitis. On the other hand, some authors believe that a nonbacterial prostatitis 
is a physiologic hypersecretion of prostatic fluid [87,88] or fluid stagnation in the 
lumen of the prostate [51,86,89], maybe enhanced by elevated prostatic fluid 
viscosity [43]. According to McKenzie (87) and Nelson [89], nonbacterial prostatitis 
is caused by prostatic congestion. They recommended treatment with DES. Only 
those patients who had a abacterial prostatitis responded favorably to estrogen 
therapy. A dose of 0.1 mg daily was established as optimum. The treatment was 
maintained for 3 months and in many patients continued more or less indefinitely. 
No side effects were seen [87]. 
From this overview, we may conclude that in view of the uncertain aetiology of 
non-bacterial prostatitis, there is no specific therapy available. The majority of 
patients will receive antibiotics, the rationale being the possibility of an occult 
infection, or a past history of non-specific urethritis, or the conception that 
chlamydiae of mycoplasmas are to blame. Besides antibiotics frequently muscle 
relaxants, anticholinergic agents, anti-inflammatory agents, the use of hot sitz 
baths, dietary restrictions or homeopathic "medication" are prescribed [90-92]. 
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Prostatodynia: Little is known about the treatment of prostatodynia. An important 
component in the management of the patient with this problem involves the 
elimination of extraprostatic causes, explaining the symptomatology. Urodynamic 
investigations in patients with prostatodynia are warranted if voiding disturbances 
constitute a major component of the symptomatology [46-48,93-95]. In several 
studies, the results of the medical treatment in patients with prostatodynia and 
urodynamic abnormalities have been described. These patients seem to respond 
favorably to therapy using alpha-receptor blockers (66,67,69). Therefore it seems 
logically that we should focus further research of patients with prostatodynia on 
micturition problems. Although only a few studies - concerning prostatodynia or 
related symptomatology with urodynamic abnormalities - have been performed, 
results of medical treatment seem very promising. 
CONCLUSIONS 
Any discussion on recent advances in prostatitis starts from a disadvantaged 
position clothed in pessimism and Stamey in 1981 concluded that 'little more is 
known about prostatitis than was reported by Hugh H. Young and associates in 
1906'. 
The diagnosis of prostatitis is made commonly by the clinician but seldom 
reflects standard methods of diagnosis. The actual cause of most cases of nonacu-
te prostatitis remains unclear; likewise, many uncertainties exist regarding the 
pathogenesis of nonbacterial prostatitis, which constitutes the most prevalent type 
of prostatitis. We would like to recommend urine analysis, urine culture, urine 
cytology, the 4-glass test and uroflowmetry as screening modalities in patients with 
prostatitis. Sonography of the kidneys and the prostate and the plain abdomen X-
ray are of limited use in the screening of patients with prostatitis. 
Outcome of treatment programs sometimes seem conflicting and many urologists 
remain perplexed about the management of prostatitis If a bacterial infection is 
found, appropriate antibiotics should be administered if available. Untili now, there 
is no rationale for antibiotics treatment in all other patients. Because symptoms 
vary from patient to patient and response to any given therapy is also quite 
variable, specific therapy should be tailored individually. Some patients improve 
with antimicrobial therapy but unless the response is favorable, further use of 
antimicrobial agents is seldom justified. Irritative symptoms and discomfort often 
are relieved by the use of muscle relaxants, anticholinergic agents or anti-inflamma-
tory agents. In case of an improved uroflowmetry, one should screen for pelvic 
floor abnormalities or a bladder dysfunction These patients may gain good results 
from an alpha-1 receptor blocking agent. 
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OUTLINE OF THESIS 
The diagnosis of prostatitis is often made by the clinician, but this is rarely ac-
companied by objective evidence Indeed, the available data have been so poor that 
the existence of prostatitis as a disease entity has been questioned Due to the 
extreme difficulty of obtaining clear diagnosis and lack of successful treatment, this 
urologie entity remains poorly understood. As a result, the term "prostatitis" unfor-
tunately, is all too often a wastebasket of clinical ignorance, used to describe any 
condition associated with prostatic inflammation or prostatic symptoms. However, 
within the last decades, many investigators have placed the field on a more sound 
scientific base, with major improvements in diagnosis and treatment of these pa-
tients. The purpose of this thesis is to review the recent advances in diagnosis and 
treatment of the various forms of prostatitis 
In chapter 1 an overview is presented at where we stand at the moment with re-
gard to diagnosis and treatment of patients with "prostatitis". Moreover the conclu-
sion from this chapter may be that prostatitis can not be seen as one entity but one 
can better use the term "prostatitis syndromes"; patients may suffer from a whole 
scala of complaints e.g. perigenital pain, irritative voiding and/or voiding dysfuncti-
on. The localization studies are used for classification of these syndromes based on 
the presence of absence of objective evidence of prostatic inflammation. If bacteria 
are cultured in the prostatic fluid, the diagnosis bacterial prostatitis is made. If no 
bacteria are grown on culture but an elevated leucocyte count is found in the pros-
tatic fluid the diagnosis non-bacterial prostatitis is made. All other cases are diagno-
sed prostatodynia. 
Although this localization test is the golden standard for diagnosis of prostatitis, 
its interpretation is not reliable Since the cause of prostatitis syndromes is un-
known, definitive therapy is difficult. From a therapeutic standpoint, the differen-
tiation between bacterial prostatitis and nonbacterial prostatitis or prostatodynia is 
clearly the most important Although no signs of infection are found, in many pa-
tients with prostatitis syndromes, an antimicrobial therapy is the most frequently 
advocated treatment. Therefore a retrospective study was conducted to evaluate 
the efficacy of the different diagnostic modalities in these patients at our departe-
ment. Moreover, the results of antimicrobial treatment were reviewed (Chapter 3). 
Because from the outcome of the aforementioned review, we wanted to be infor-
med about the current situation among the Dutch urologists and general practitio-
ners with regard to diagnostic work up and treatment of patients with prostatitis 
syndromes. We wanted to answer the following questions: how many patients 
present themselves with prostatitis complaints to the general practitioners? what is 
the choice of treatment in these patients? what is the outcome? how many patients 
are being referred to the urologist7 what is the choice of treatment by the urolo-
gist? How are the results that have been achieved? Finally, we wanted to give 
recommendations as to which type of tests are best suited for screening in order to 
select the proper treatment (Chapter 4). 
Psychological factors have been considered as playing an important role in the 
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aetiology of chronic prostatitis. In general, urology patients as a group tend to exhi­
bit a wide spectrum of psychiatric problems. Among urologists, there is a widely 
held belief that neurotic patients have many complaints in the genito-urinary region. 
A failure to respond to any given treatment for prostatitis complaints may possibly 
be the result of psychosomatic or psycho-neurotic conditions in these patients. In 
Chapter 5 we wanted to clarify this. 
Interstitial cystitis, carcinoma-in-situ and invasive bladder tumors may cause com­
plaints resembling to those of prostatitis patients and can be ruled out with urine 
cytology and cystoscopy. Although recommended, no exact data are available 
concerning the validity of this investigation. To our knowledge we conducted the 
first study with regard to this subject (Chapter 6). 
Prostatic imaging may be helpful in the diagnosis of inflammatory disorders. To 
be of potential value, it should give urologists additional information that cannot be 
obtained by conventional diagnostic methods. However both characteristic and not 
specific features have been described. Because of these contradictions, we conduc­
ted a study in which the echographic images of the prostate in patients with pros­
tatitis were compared with those of a healthy control group (Chapter 7). To overco­
me subjectivity in the interpretation of these ultrasound images we used image 
analysis techniques to see if with this technique it is possible to differentiate be­
tween non-inflammated and inflammated prostate tissue. The advantage of this 
analysis can be that information in the image, hidden for the human eye, is detec­
ted (Chapter 8). 
Uroflowmetry abnormalities are reported in 30 percent of the patients with pros­
tatitis syndromes. Urodynamic testing in these patients has frequently shown func­
tional disorders of the lower urinary tract. Furthermore it is known that in the blad­
der base, the proximal urethra and the prostate smooth muscle contain predomi­
nantly σ,-receptors. These σ,-receptors mediate smooth muscle relaxation. Thus σ,-
receptor blockage will cause a smooth muscle relaxation in the bladder base, the 
proximal urethra and the prostate. Therefore we conducted a study in which we 
used alfuzosin (a new σ,-receptor blocking agent) in patients with prostatitis syn­
dromes, mainly presenting with micturition complaints (Chapter 9). 
Finally, in Chapter 10 a summary and the conclusions of this thesis are presented 
in English and in Dutch. 

Chapter 3 
DIAGNOSTICS AND TREATMENT OF 409 PATIENTS WITH PROSTATITIS 
SYNDROMES. SURVEY OF RESULTS. 
J.J.M.C.H. de la Rosette, M.R. Hubregtse, E.J.H. Meuleman, M.V.M. Stolk-Engelaar, 
F.M.J. Debruyne. 
Urology 1993;41:301. 
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ABSTRACT 
We reviewed 409 patients who had prostatitis syndromes during the period 
1985-1991. Urine analysis, x-ray film of abdomen, and sonograms of the kidneys 
did not contribute to the diagnosis of prostatitis. In 22 percent of the urine sam-
ples, slight-to-moderate atypia was seen in urine cytology but no malignancy was 
found. Uroflowmetry data were abnormal for 30% of the patients, and thus 
uroflowmetry may contribute to treatment selection of patients who may gain from 
specific drugs such as the newly developed alpha-1 receptor blocking agents. 
Positive bacteria cultures were found in 10,4 percent of the cultures of the pros-
tatic fluid and in 14,3% of the cultures of the urethra. Ureaplasma urealyticum was 
seen in 19,6 percent of the cultures of the prostatic fluid and in 32 percent of the 
cultures of the urethra. Prostatic fluid did not give additional information, and the 
outcome of semen cultures showed a poor correlation with urethra or prostatic fluid 
cultures. 
In this series, the most advocated treatment remains the antibiotic treatment 
(75% of patients) bringing relief of complaints in 35.6 percent of the patients and 
cure in 23.8 percent. However, similar results were found if no antibiotics were 
administered (relief of complaints in 31,6% and cure in 30,5%) and more than one 
course of antibiotics did not improve these results. Consequently, we advocate the 
use of specific antibiotics only when the causative bacterial agent has been identi-
fied. 
Diagnostics and treatment 31 
INTRODUCTION 
Prostatitis is a condition in adult men associated with a variety of complaints 
located in the lower abdomen and perineum [1). A study by the US National Center 
for Health Statistics showed that, if men were seen for urogenital problems, 
approximately 25% of these were for a prostatitis [2]. Also, it has been estimated, 
that 50% of men will experience symptoms of prostatitis at some time in their lives 
[3]. 
Although the term "prostatitis" implies an infectious disease, serious doubt exists 
as to the infectious origin of the condition in some cases. Infectious causes have 
been the most widely studied, but only 5% of patients were found to have a 
bacterial infection. For a diagnosis, the prostatic localization test, often called the 
Stamey-Meares, or four-glass test is recommended. The majority (95%) seems to 
suffer from a disease related to the prostate but no significant bacteria can be 
cultured from their prostatic fluid. Sixty perceant of these patients are believed to 
suffer from non-bacterial prostatitis because the prostatic fluid reveals an elevated 
leucocyte count, although the search yields no causative agent In the remaining 
patients, no signs of infection are found, and this condition is denoted as prostato-
dynia In the latter group, extraprostatic causes are suspected, e.g., disorder of the 
bladder outlet [4] , detrusor hyperreflexia [5] or pelvic floor tension myalgia 16]. 
Interstitial cystitis and carcinoma-m-situ of the urinary bladder may give similar 
complaints as prostatitis, and should be ruled out with cytology of the urine and 
cystoscopy [7]. If necessary, a bladder biopsy should be performed Osteitis pubis 
or urolithiasis may also mimic prostatitis, and for this reason a radiographic 
screening is advised. 
Since the cause of prostatitis syndromes in most patients is unknown, definitive 
therapy is difficult. Although no signs of infection are found, in many patients with 
prostatitis, an antimicrobial therapy is the most frequently advocated treatment. 
There is evidence that some patients will improve with this therapy. 
This retrospective study was conducted to evaluate the efficacy of the different 
diagnostic modalities in patients with prostatitis. Moreover, the results of antimicro-
bial treatment were reviewed. 
MATERIAL AND METHODS 
Prostatic fluid samples and/or semen cultures were collected from 409 patients 
during the period 1985-1991. All patients presented with prostatitis syndromes. 
In this retrospective study the following parameters were analyzed: age, duration 
of complaints, kind of complaints, urine analysis, urine culture, urine cytology, 
sperm culture, prostatic exprímate culture, urethral culture, uroflowmetry, x-ray film 
of abdomen, sonograms of the kidneys, choice of antibiotics, result of treatment. 
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RESULTS 
The age of the patients ranged from nineteen to eighty-five years (mean 42 
years). The age distribution and treatment results are shown in figure 1. Complaints 
were pain, irritative bladder symptoms, urethral discharge and haematospermia 
(Table 1). Most patients (37,5%) were complaining for less than six months and 60 
patients (15,5%) were seen with complaints lasting at least five years. 
Urine showed no abnormalities in 69 percent of the samples, in 22 percent of 
them 0-5 erythrocytes per high power field and in 9 percent (n = 36), more than 5 
erythrocytes per high power field were found. In 65 percent of the urine samples 
no leucocytes were found and in 27 percent and 8 percent (n = 31), 0-10 and more 
than 10 leucocytes per high power field, respectively, were found. The results of 
the urine cultures are presented in Table 2. 
Urine cytologic studies were performed for 193 patients. In 70 percent no abnor­
malities were found; in 8 percent signs of infection and in 22 percent signs of 
slight-to-moderate atypia were found, respectively. In these patients malignancy 
was excluded by urethrocystoscopy (UCS), bladder biopsies and intravenous 
urogram (IVU). 
Figure 1. Age distribution and treatment results in patients with prostatitis 
syndromes. 
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Table 1. Complaints and symptoms of patients with prostatitis syndromes. 
Complaints No Patients 
Pain 
-Penoscrotal pain 202 
-Suprapubic pain 148 
-Perineal pain 88 
-Pain in groins 86 
-Backpain 49 
-Pain during ejaculation 39 
Irritative bladder symptoms 
-Frequency 159 
-Stranguria 148 
-Dribbling 144 
-Dysuria 61 
-Hesitation 49 
Other symptoms 
-Urethral écoulement 57 
-Haematospermia 27 
-Haematuria 14 
In 6 patients, all known with urolithiasis, prostatitis was encountered in combina-
tion with urolithiasis. In these patients, the complaints of prostatitis seemed not 
related to urolithiasis (table 3). 
In 23 patients kidney abnormalities were found by ultrasound. These abnorma-
lities were: calix diverticulum (1), horseshoe kidney (1), sponge kidney (2), shrun-
ken kidney (2), cysts (7) dilated renal pelvis (4) and kidney stones (3). No treatment 
was required, except for patients with kidney stones. 
In 260 patients, uroflowmetry was performed and in 199 patients the volume of 
micturition was at least 150 mL. Flow rate ranged from 4 to 56 mL/s (average 20 
mL/s) and volume ranged from 38 to 933 mL (average 299 mL). Residual urine over 
50 mL was found in 25 patients (54-300 mL) of whom 64 percent had a maximal 
flowrate less than in the 25th percentile (figure 2). 
The results of the urethral cultures are shown in Table 2. Ureaplasma urealyticum 
was cultured in 32 percent, while bacteria were cultured in 14,3 percent of 
samples. In 2 patients, trichomonas and in 1 patient a candida was found. The 
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results of the prostatic exprimate cultures are shown in Table 2. This was not done 
for 26 patients. Ureaplasma urealyticum was seen in the majority of cultures 
(19,6%). Bacterial cultures were positive in 40 patients (10,4%), sometimes in 
combination with Ureaplasma urealyticum. Fungi were only cultured in 1 patient. In 
140 patients sperm cultures were performed. These cultures were negative in 79 
percent, and in 16 percent positive bacterial cultures were met. Ureaplasma urealy-
ticum was cultured in 1 patient only (Table 2). If bacterial cultures were positive in 
urethral (n = 56) and/or prostatic (n = 40) cultures, this was confirmed in a minority 
of the semen cultures (n = 7). On the other hand, in 22 patients, sperm cultures 
were positive for bacteria but this could only be confirmed in 7 patients after the 
four-glass test. 
Table 2. Results of the urine, prostatic exprimate, urethral and semen cultu-
res and the number of positive cultures. 
Results of culture 
Ureaplasma urealyticum 
Mixed flora 
ß-hemolytic streptococci group В 
ß-hemolytic streptococci group G 
Escherichia coli 
Staphylococcus epidermidis 
σ-hemolytic streptococci 
Staphylococcus aureus 
Proteus mirabilis 
Enterococci 
Trichomonas 
Candida albicans 
Klebsiella oxytoca 
Enterobacteragglomerans 
Diphtheroid rods 
Citrobacter freundii 
Pseudomonas aeruginosa 
Morganella morganii 
Negative 
Urethra 
126 
39 
18 
1 
10 
10 
9 
9 
7 
4 
2 
0 
0 
208 
Prostate 
75 
14 
8 
1 
12 
4 
0 
8 
4 
9 
0 
1 
1 
0 
0 
1 
0 
0 
268 
Urine 
1 
16 
2 
0 
13 
5 
6 
0 
4 
1 
0 
0 
1 
0 
2 
0 
1 
0 
322 
Seme 
1 
10 
3 
0 
8 
0 
2 
1 
2 
2 
0 
0 
1 
0 
1 
0 
0 
1 
111 
Diagnostics and treatment 35 
In 95 patients (25%) no antibiotics were administered. If antibiotics were given, 
in 216 patients tetracycline was the drug of choice, in 117 patients quinolones, in 
110 patients sulfotrim-cotrimoxazole, in six patients pipemidine acid and in four 
patients nitrofurantoin. In 120 patients these drugs were given sequentially, in 100 
patients two drugs and in 20 patients three drugs, respectively. The period of 
treatment ranged between four to six weeks. 
The results of treatment were analyzed according to whether or not the antibio­
tics were administered. If no antibiotics were given, 31.6 percent of the patients 
improved, while 30.5 percent were without complaints. If antibiotics were adminis­
tered (one or more courses), in 35.6 percent relief of complaints were noticed, 
while 23.8 percent were without complaints (Table 4). Evaluation of the results of 
treatment with regard to the number of antibiotics courses is shown in Table 5. 
Table 3. Patient with abnormality shown on abdominal x-ray film and subse­
quent treatment. 
Case No. 
A 
В 
С 
D 
E 
Deviation 
Small concrement renal pelvis 
Concrement both kidneys 
Small concrements in calyx 
Multiple concrements both kidneys 
Concrement in renal pelvis 
Sponge kidney 
Treatment 
ESWL 
Pyelotomy in the 
past 
none 
none 
ESWL/Pyelotomy in 
the past 
none 
Table 4 Results of treatment versus use of antibiotics. 
Antibiotics No Unchanged Improved No Complaints Worse Unknown 
Yes 314 36,3% 35,6% 23,8% 1,6% 2,7% 
No 95 32,6% 31,6% 30,5% 0,0% 5,3% 
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Table 5. Results of treatment versus the number of courses of antibiotics. 
Course No patients Unchanged Improved No Complaints Worse Unknown 
0 
1 
2 
3 
95 
194 
100 
20 
32,6% 
30,9% 
44,0% 
50,0% 
31,6% 
35,0% 
38,0% 
25,0% 
30,5% 
29,4% 
15,0% 
15,0% 
0,0% 
2 , 1 % 
0,0% 
5,0% 
5,3% 
2,6% 
3,0% 
5,0% 
DISCUSSION 
Although prostatitis appears to be one of the most common pathologic conditions 
encountered in urology, a number of questions have as yet to be answered con-
cerning its aetiology, diagnosis and treatment. 
The age distribution in the present study is comparable with that reported 
elsewhere [8,9]. In that study the main complaints appeared to be low back pain 
and/or perineal pain. Unlike the aformentioned study, ours also frequently featured 
patients with penoscrotal and suprapubic pain. 
The duration of complaints at presentation varied between several months and 
frequently just over a year. As our hospital is a regional referral centre, both groups 
of patients are frequently encountered here The duration of complaints before 
treatment was not a factor in determing the success rate of the treatment. 
Erythrocytuna (more than 5 erythrocytes/HPF) was found in 9 percent of the 
patients (n = 36), while 25 percent of these patients had a positive urine bacterium 
culture. Of the patients screened for prostatitis with erythrocytuna, 6 had urolithia-
sis, while none had malignancies. Leucocytuna (more than 10 leucocytes/HPF) was 
found frequently and was associated with positive bacterium urethra cultures 
and/or prostatic liquid cultures in 17 of 31 patients considered. Thus, not suprism-
gly, leucocytuna afforded another confirmation of an existing bacterial infection. 
Indeed, urine analysis should always be done for these patients 
Urine cytology, and if positive UCS with biopsies and an IVU, is required in order 
to exclude the bladder carcinoma-in-situ. This study revealed shght-to-moderate 
atypia in 22% of urine samples. However, tests employing IVU and UCS with 
biopsies revealed no abnormalities in the aforementioned cases. At this juncture, 
one might well ponder the wisdom of continuing the cytologic screening of patients 
who present with prostatitis syndromes. 
In another study of 206 prostatitis patients, 6 patients (2,9%) had urine bladder 
malignancies (in press) It is for this reason that we recommend that urine cytology 
be performed for patients presenting with prostatitis syndromes The merits of 
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ultrasound of the kidneys are questionable. In the few patients where urolithiasis 
had been diagnosed, the diagnosis had been known before. Ultrasonography of the 
kidneys yielded no correlation with the complaints presented and had therefore no 
auxiliary value for the eventual therapy. 
Uroflowmetry abnormalities as, for example poor flow, were reported in 30 
percent of cases [8]. In our study we frequently saw micturition problems which 
implies that these patients may be suffering from extraprostatic causes, e.g., pelvic 
floor tension myalgia [6] or disorder of the bladder outlet [4]. In a recent study of 
ours, we booked good results, both objectively and subjectively, treating patients 
who had prostatodynia and urodynamic abnormalities, with alpha 1 - receptor 
blockers. These positive results suggest that e.g. pelvic floor tension myalgia may 
indeed be important etiologically in many patients with prostatitis syndromes. 
Therefore, uroflowmetry should always be performed for patients with prostatitis 
syndromes. Uroflow volume should be at least 150 mL and if possible more than 
one uroflowmetry should be performed. Should uroflowmetry show a deteriorating 
condition, one should carry out further urodynamic investigations. 
The classification of patients with prostatitis is based on a judicious bacteriologie 
assessment of the lower urinary tract according to the technique of Meares and 
Stamey. Results of these localization studies permit classification of men with 
prostatitis syndromes into three diagnostic groups, namely: bacterial prostatitis, 
"nonbacterial" prostatitis, and prostatodynia [1]. In patients with a bacterial 
infection, the prostatic fluid is cultured for bacteria. In a "nonbacterial" prostatitis, 
no bacteria are cultured but an elevated leucocyte count is found in the prostatic 
fluid. In prostatodynia, no bacteria are grown on culture, and no signs of leucocyto-
sis are seen. 
For diagnosis of patients with prostatitis syndromes, the four-glass test is used. 
However, the major problem in diagnosis of these patients remains the evaluation 
of the four-glass test. Furthermore, this test is rarely used by clinicians, because it 
has a low sensitivity; its interpretation criteria are, as yet, not unambigiously 
defined [10,11]; it taxes the patients, is time consuming and is relatively expensive. 
For these reasons the usefulness of this prostatic loxahzation test has been 
confined solely to the research trials of prostatitis treatment. 
Greenberg et al. found that the enologie agent of chronic prostatitis could not be 
identified in 83 percent of the cases [8]. When it could be identified. Streptococcus 
feacahs, Enterobactenaceae, and pseudomonads were the most frequent pathogens 
[3,12,13]. These results are confirmed by our findings, showing positive bacterium 
cultures in the prostatic fluid in 10.4 percent and in 14.3 percent of the urethral 
cultures. The aforementioned pathogens were also encountered frequently in our 
series (see table 2). 
These results point to the need for an increased sensitivity of the present cultures 
for the pathogens, which should include anaerobes. Chlamydia trachomatis and 
mycoplasma species Weidner, Schiefer, and Krauss [141 think that in addition to 
the well-known urogenic Enterobactenaceae and enterococci, C. trachomatis and 
U.urealyticum must be considered as the particularly important aetiologic agents in 
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Figure 2. Nomogram for maximum urine flow rates (mL/sec) as a function of 
the urine voided volume (mL| in prostatitis patients (A) younger 
than fifty years, and (B) older than fifty years. 
Maximum urine flow rate(ml/sec) 1
 я 
ι ι ι ι ι 
200 400 600 
Voided volume (ml ) 
Maximum urine flow rate (ml/sec) 
60 
50 
LO 
30 
20 
Ι Ο ­
Ι ι ι ι 
200 ΑΟΟ 600 
Voidedvolume (ml ) 
Men 50yrs. and over (median 60) 
Diagnostics and treatment 39 
prostatitis The prostatitis patients showed an incidence of 14 percent of U.urealyti-
cum [15,16] and 18.3% of C.trachomatis [17] in the respective cultures. Peeters 
[9] showed that U.urealyticum could be isolated from 26 percent of healthy men 
and from 47 percent of patients with prostatitis. A serological study showed that 
49 percent of the patients had antibodies to C.trachomatis, in contrast to 18 
percent of the controls [9]. These patients responded favorably to an antibiotics 
treatment. However, subsequent studies have been unable to corroborate this 
conclusion [18,19]. In the present study, U.urealyticum was cultured in 32 percent 
and 19,6 percent of urethral and prostatic fluid, respectively. With regard to the 
aforementioned results and suggestions, we think that we should focus also on 
C.trachomatis and U.urealyticum concerning screening patients with prostatitis 
syndromes. Furthermore, this study showed that positive cultures of the prostatic 
fluid could always be confirmed by positive cultures of the urethra. Consequently 
urethral cultures may, because of the nice match with the prostatic fluid cultures 
and the minor discomfort to the patients, replace cultures of the prostatic fluid in 
our general clinical practice. 
Finally, the value of semen cultures seems limited because of the poor correlation 
between the results of these semen cultures and the "Meares" cultures. Furthermo-
re, U urealyticum was only found once. Eijsten, Hauri, and Kronagel [20] confirmed 
this result and stated that bacteriologie tests of the ejaculates do not yield as 
reliable results as the four-glass test. Perhaps in the ejaculate only the prostatic 
fluid from the central prostatic part is collected while after a prostatic massage 
mainly the prostatic fluid from the peripheral zone is obtained. Because most 
infections are found in the peripheral zone, this difference seems understandable. 
However, these findings are in conflict with the results from a study by Christian-
sen and Purvis [21], who reported that no difference was found between the 
results of a bacterial culture using Stamey's four-glass method or aliquot of the 
ejaculate. Nevertheless, we do not advise to replace semen cultures by cultures 
using Stamey's method, because of the poor correlation found in this study. 
Because it is assumed that men with genitourinary symptoms, have a prostatic 
focus of infection, some clinicians treat them with an antibiotic that achieves 
adequate prostatic concentrations, such as trimethoprim, doxycycline or qumolones 
[10]. Despite a prolonged (6 to 12 weeks) administration of these agents, failure to 
eradicate bacterial prostatitis is usually 30 percent to 40 percent [10,14]. However, 
nonbacterial prostatitis is far commoner than proven chronic bacterial prostatitis, its 
cause is unknown, and antibiotics therapy is rarely beneficial. 
In 75 percent of patients who were treated with antibiotics, a cure rate of about 
23,8 percent was achieved and in 35 6 percent a relief of complaints was ob-
tained. The most frequent advocated compound was tetracycline, followed by 
qumolones and sulfotrim-cotrimoxazol. There was no difference in the cure rate 
related to the kind of antibiotics used. Possible explanations for this finding are. 
poor penetration by an antibiotic, recurrence of infection or complaints not caused 
by infection (e.g. in pelvic floor tension myalgia). Should the patients not improve 
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after having been given one course of antibiotics, we found that subsequent 
courses of antbiotics did not produce a higher cure rate. These results are in 
agreement with those reported by others. Meares [22] reported that approximately 
one third of patients are cured within three months of therapy when receiving a 
sulfamethoxazole-trimethoprim only, and also Drach [23] reported a cure rate of ap­
proximately one-third of all patients with prostatitis treated with an antimicrobial 
medication. Schaeffer et al [24] think a three-week course of tetracycline or 
erythromycin appropriate for these patients. In view of the rather disappointing 
results achieved with co-trimoxazole and trimethoprim, other agents have been 
explored The antimicrobial agents receiving most press at present are the quinolo-
nes which have been shown to reach high concentrations in prostatic secretions. 
Clinical studies have demonstrated that this antibiotic is effective and cure rates up 
to 64 percent have been reported Furthermore, it is interesting to note that 
quinolones are also active against C.trachomatis and U.urealyticum [25]. This 
would support the use of quinolones in the treatment of patients with prostatitis 
syndromes 
However, in 25 percent of the patients no antibiotics were administered and the 
cure rates were comparable with those who were given antibiotics This finding 
raises the question of whether or not these are the patients with prostatodynia and 
micturition complaints who should be treated with an alpha-1 receptor blocking 
medication? Drach [23] stated that administration of antibiotics is justified because 
of its cure rate and although low, this rate still is better than no rate at all We 
wonder whether this statement is still applicable under these circumstances 
CONCLUSION 
As a result of this study, we recommend urine analysis, urine culture, urine 
cytology, urethral culture and uroflowmetry as screening modalities in prostatitis 
syndromes If a bacterial infection is found, appropriate antibiotics should be 
administered, if available Untili now, there was no rationale for antibiotic treatment 
in all other patients However, as for as the С trachomatis and U urealyticum are 
concerned, ongoing studies may give support to the value of antibiotics in treating 
these patients. In case of poor uroflowmetry findings, one should screen for pelvic 
floor abnormalities or a bladder dysfunction These patients may favor from an 
alpha-1 receptor blocking agent. Finally, the sonography of the kidneys and x-ray 
films of the abdomen are of limited use in the screening of patients with prostatitis 
syndromes. 
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ABSTRACT. 
By means of a questionnaire, all Dutch urologists (n = 250, 136 responded) and 
regional general practitioners (GP's; η = 400, 176 responded) were contacted 
concerning current diagnostics and treatment modalities applied in patients with 
prostatitis syndromes. The patients seen by urologist seem to be younger (30-40 
years) and they mostly complain of pain in the perineum, penis or scrotum, while 
GP's see older patients (> 40 years) mainly presenting with micturition complaints. 
Urologists think nonbacterial causes (40%) most important, while GP's mention 
bacterial infections (63%) as the most important cause. The first choice of therapy 
is antibiotics, mostly co-trimoxazole-Sulfatrim for 3 weeks, but patients seen by 
urologists are more resistant to this therapy. If not successful, urologists frequently 
prescribe a second course with antibiotics. However, many urologists consider 
psychosomatic causes an important factor in the etiology of prostatitis. 
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INTRODUCTION. 
The term 'prostatitis' is often employed to describe any unexplained symptom or 
condition that might possibly originate from the prostate gland. The diagnosis in 
these patients is difficult and treatment often unsuccessful. Little is known 
concerning the incidence of these conditions in the general population, etiology, 
choice of treatment and therapeutic results. A study by the National Center for 
Health Statistics [1] showed that in the United States, in 1977-1978, there were 
19 office visits for prostatitis annually per 1,000 men for urogenital problems. That 
study supplied only few data on the etiology of prostatitis. 
For diagnosis, the four-glass test developed by Stamey and Meares is recom­
mended, while other causes may be excluded by abdominal X-ray, renal sonogra­
phy, uroflowmetry and urine cytology. Infectious causes are found in only 5-10% 
of patients, the majority suffer from nonbacterial prostatitis or prostatodynia [2,3]. 
However, in spite of this result, antimicrobial drugs are the first-choice treatment of 
prostatitis. 
Since the cause is frequently unknown, it is difficult to select a therapy. In a 
recent study, we reviewed the diagnostics and therapeutic results of 409 patients 
with prostatitis seen at the Department of Urology during 1985-1991. Urinalysis, 
abdominal X-ray and renal sonography were not instrumental in the diagnosis of 
prostatitis. Since 30% of the patients had abnormal results on uroflowmetry, this 
method may help selecting patients who may benefit from non-antibacterial 
treatments (e.g. σ1-receptor blockers). 
10,4 percent of the prostatic fluid cultures were positive for bacteria; Ureaplasma 
urealyticum was seen in 19,6 percent of them. Although the outcome of the 
different screening modalities was disappointing (only a minority showed positive 
bacterial cultures), the most frequently advocated treatment was antibiotics (75% 
of patients), bringing relief of complaints in 35.6 percent of the patients and cure in 
23.8 percent. However, similar results were found if no antibiotics were administe­
red (relief of complaints in 31,6 percent and cure in 30,5 percent). More than one 
course of antibiotics did not improve these results. 
Because of the outcome of this study, we wanted to be informed about the 
current situation among the Dutch urologists and general practitioners (GP's) with 
regard to diagnostics and treatment of patients with prostatitis syndromes. Finally, 
we wanted to give recommendations as to which type of tests are best suited for 
screening in order to select the proper treatment. 
MATERIALS ANS METHODS. 
250 urologists and 400 GP's were contacted by means of a written question­
naire. The information that was requested concerned patients that had been treated 
for prostatitis, and included age of the patients, the kind of complaints, etiology, 
diagnostics, therapeutics, success rate and natural history. 
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RESULTS. 
The response rate was 54 percent among the urologists (n=136) and 44 percent 
among the GP's (n= 176). Most responding GP's have a practice with 2,000-3,000 
patients. 
Epidemiology: GP's see approximately 5 patients per year with complaints of 
prostatitis and refer one third of these patients to a urologist. The GP's frequently 
see patients older than 40 years of age who mainly have micturition complaints. 
Most urologists see up to 50 patients a year. In contrast to the patients seen by the 
GP's, these patients are 30-40 years old and most frequently complain of pain in 
the perineum, penis or scrotum. 
Etiology: Two-thirds of the GP's consider bacterial infection as the main cause of 
prostatitis complaints. Urologists, on the other hand, consider nonbacterial infecti-
ons the most important causes (fig. 1). Psychosomatic causes contribute up to 50 
percent to chronic prostatitis, in contrast to the findings from the GP's (fig. 2). 
About 40 percent of the GP's and 65 percent of the urologists envisage a psycho-
somatic component. 
Figure 1 Etiology of prostatitis reported by GP's and urologists: a = bacterial 
infection, b = non-bacterial infection, c = bladder and pelvic floor 
dysfunction, d= psychosomatic. 
Figure 2 Incidence of psychosomatic factor reported by GP's and urologists. 
Figure 1 Figure 2 
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Diagnostics: The results of this question are given in table 1. Almost 10% of the 
urologists perform an intravenous urogram (IVU) for screening and the others, in 
about half of the cases, an abdomen X-ray and a renal sonography. GP's seldom 
ask for an IVU, an abdomen X-ray or a renal sonography. Fifty percent of the 
urologists perform semen cultures, while others also perform a prostate massage 
with cultures according to Meares and Stamey (table 2). These investigations are 
rarely performed by GP's Cytologic examination is done in 35 percent of cases and 
uroflowmetry in 65 percent Finally sonography of the prostate is being performed 
by 55 percent of the urologists. 
Table 1 Tests performed by GP's and urologists on patients with prostatitis. 
GP UR 
Diagnostics yes no yes no 
Rectal examination 
scrotal examination 
IVU 
Abdomen X-ray 
sonography kidneys 
sonography prostate 
semen cultures 
exprímate cultures 
urine cytology 
uroflowmetry 
174 
137 
6 
4 
8 
0 
14 
22 
0 
0 
2 
39 
170 
172 
168 
176 
162 
143 
176 
176 
134 
134 
13 
64 
75 
74 
66 
70 
49 
90 
2 
2 
123 
72 
61 
62 
70 
66 
87 
46 
Table 2 Number of semencultures and/or exprímate cultures performed by 
urologists. 
exprimate cultures 
yes no total 
30 36 66 
40 30 70 
70 66 136 
semenculture 
yes 
no 
total 
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Treatment: Both GP's and urologists prescribe antibiotics and analgetics and give 
supportive general advice. The first-choice antibiotics of GP's is co-trimoxazole-
Sulfatrim, followed by tetracycline and quinolones during a period of 2-3 weeks. 
The first choice of urologists is also co-trimoxazole-Sulfatrim, followed by quino­
lones as second choice, administered over 3-4 weeks (fig. 3). This scheme of treat­
ment is successful in 50-75 percent and 25-50 percent of the cases, according to 
the GP's and the urologists, respectively (fig. 4). Recurrence is seen more frequent­
ly by urologists (75%). If the first course is not successful, 82 percent of the GP's 
and 78 percent of the urologists prescribe a second course with different antibio­
tics. 
Figure 3 Comparison of antibiotics chosen for treatment by GP's and urolo­
gists: a = co-trimoxazole-Sulfatrim, b = tetracyclic с = quinolones. 
Figure 4 Success rate of treatment reported by GP's and urologists. 
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DISCUSSION. 
The diagnosis of prostatitis is made commonly by the clinician but seldom 
reflects standard methods of diagnosis and treatment. There are varied criteria to 
define 'prostatitis', and the outcome of treatment programs sometimes seem 
conflicting. Patients with protatitis syndromes are frequently seen by the urologists, 
and they seem to afflict 35 percent of all male subjects at some time during their 
lives. Moreover, little is known about patients who are seen for prostatitis by the 
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GP's and their choice and result of treatment. 
The results of this questionnaire show that GP's refer about one third of patients 
with complaints of prostatitis to a urologist. It is interesting to see that the com-
plaints of these patients, as descibed by the urologist and the GP's show remarka-
ble differences. Drach [4] reported that a large number of normal individuals with 
benign prostatic hyperplasia also has evidence of prostatic inflammation. As GP's 
frequently reported on patients older than 40 years of age who mainly had micturi-
tion complaints, we question whether many patients seen by the GP's are not just 
suffering from prostatism due to benign prostatic hyperplasia. 
Little is known concerning etiology in patients with prostatitis syndromes. In one 
large clinic specialized to the treatment of men with inflammatory prostatic sympto-
matology, 5 percent of 597 patients were found to have chronic bacterial prostati-
tis, 64 percent apparently had nonbacterial prostatitis and 31 percent had prostato-
dynia [2]. In the present study, urologists agree with these findings. However, in 
contrast, two-thirds of all GP's consider bacterial infection as the main cause of 
prostatitis. The distribution of bacterial and nonbacterial prostatitis is probably 
different in the general population compared with that seen by the urologist. 
Psychological factors may also be important etiologically in chronic prostatitis, and 
most patients benefit considerably from a frank discussion over the nature of the 
condition [5,6]. However, the results of a study by Keltikangas-Jarvinen et al. [7] 
indicate a strong need for psychic support of patients with chronic prostatitis. 
In the present study, both the GP's and the urologists believe psychosomatic 
causes contribute to chronic prostatitis. Again there is an evident difference in 
opinion regarding this subject. As urologists see patients who did not respond to 
earlier therapy, in whom diagnostic test were unrewarding and therapy difficult, it 
seems logical that there is a strong feeling towards psychosomatic etiologies. In 
another study of ours, we found only minor psychological disturbances. However, 
patients with prostatitis scored significantly higher on depression, somatization and 
fear. Thus, we concluded that especially patients with depressive symptoms may 
benefit from psychological and antidepressive treatment (in press). 
Rectal examination should always be performed in patients suffering from com-
plaints of prostatitis. When clinically indicated, an abdominal X-ray to detect 
nephrolithiasis or an ultrasonographic examination of the kidneys to discover 
hydronephrosis should be done. An IVU should only be performed if abnormalities 
are seen on these earlier investigations or if they are not conclusive. A recent study 
carried out in our department on patients suffering from prostatitis, abdominal X-ray 
and renal sonography were of little value as a screening modality (in press). 
Cytologic examination should be performed if one suspects carcinoma-in-situ or 
urothelial cell carcinoma. This investigation is frequently done by 35 percent of the 
urologist. Our own experience is that cytology should allways be performed, 
because in 206 patients with prostatitis complaints, seen in our department, urine 
cytology revealed severe atypia in 13 patients; the cancer risk in these patients 
appeared to be 50 percent (in press). 
Uroflowmetry was performed frequently. Several authors describe urodynamic 
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abnormalities caused by striated detrusor sphincter dyssynergia or tension myalgia 
of the pelvic floor [8,9]. Also, micturition complaints, due to poor detrusor contrac-
tions, have been descibed [10]. But simple uroflowmetry may help to detect any 
signs of voiding dysfunctions and thus should be performed routinely. In the case 
of improved uroflowmetry, one should perform further screening. 
Ultrasound of the prostate was performed by 55 percent of the urologist. Several 
authors [11,12] have described characteristics ultrasound features in patients with 
bacterial and nonbacterial prostatitis. Also, one can distinguish echogenic differen-
ces which are not specific for this prostatic diseases [13,14]. Because of these 
contradictions, we already conducted a study in which the echographic images of 
the prostate in patients with nonbacterial prostatitis were compared with those of a 
healthy control group. In contrast with findings of others, we could not confirm a 
specific ¡mage in patients with nonbacterial prostatitis [15]. Thus ultrasound of the 
prostate does not seem to contribute substantially to the diagnosis in patients with 
prostatitis and is not recommended as a screening modality. 
To differentiate between the different types of prostatitis, a localization test 
according to Meares and Stamey may be performed. This investigation was 
performed by 50 percent of the urologists, while others rely on semencultures. 
Almost 20 percent of the urologists performed no cultures. As stated before, the 
four-glass test investigations were rarely performed by GP's. A major problem in 
evaluating this test is the lack of a standard against to compare it. Abnormal levels 
of leukocytes, enzymes or immunoglobulins in prostatic fluid may help to define the 
presence and cause of prostatitis, but these methods have limitations and are not 
widely available [16-18]. As the localization test is difficult to interpret, time consu-
ming, relatively expensive, and often uncomfortable for the patient, it is not 
surprising that it is rarely performed by clinicians. Thus the prostatic localization 
test is useful mainly for research trials of therapies for prostatitis. In a recent study 
of 409 patients with prostatitis syndromes seen at our department, the value of the 
outcome of semenculturs apeared limited and the use of the prostatic localization 
test was in discussion. Based on the results of this study, we would suggest to 
replace the four-glass test by urine culture combined with urethral cultures. With 
regard to diagnosis and treatment, it appeared useful to focus on Ureaplasma 
urealyticum and Chlamydia trachomatis as well as on bacteria (in press). 
The treatment in patients with persistent prostatitis or related symptomatology is 
difficult and often unsuccessful [19]. In this study, the first-choice of treatment of 
patients with prostatitis is antibiotics. Because most antibiotics achieve high 
concentrations in the acutely inflamed gland, penicillins, cephalosporins, aminogly-
cosides and other agents are effective. However, despite prolonged (6-12 weeks) 
administration of these agents, failure rates in chronic bacterial prostatitis are 
usually 30 to 40 percent [20]. Treatment of chronic prostatitis is generally hampe-
red by the poor penetration of most antibiotic agents into noninflamed prostatic 
tissue and secretions. According to Lipsky [21], recurrent infections in men require 
at least 6 weeks of appropriate treatment. 
In this study, both urologists and GP's selected co-trimoxazole Sulfatrim as the 
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treatment of choice, which they applied for a period of 3-4 and 2-3 weeks, 
respectively The choice of drug is generally accepted by most urologist but one 
may question the use of the same drug by the urologist and his referring GP. On 
the other hand the period of drug administration in these patients was not the 
required 6-week treatment period. Meares [22] reported that approximately one-
third of the patients are cured in 3 months when receiving sulfamethoxazole/trime­
thoprim only. This success rate after antibiotic treatment was also reported by the 
urologists in the present study. It seems evident that the referring GP's reported 
higher success rates. The results of treatment with antibiotics in general seem 
rather disappointing, and the use of more than one course with antibiotics should 
not be advised. 
Based on the results of this study and the results of diagnostic tests and treat­
ment of patients seen at our department, we recommend urine analysis, urine 
culture, urine cytology, urethral cultures and uroflowmetry as screening modalities 
in prostatitis syndromes. With regard to diagnosis and treatment, the attention 
should be focusssed on bacteria and on U. urealyticum and C. trachomatis. The 
results of treatment with antibiotics in general seem rather disappointing, and the 
institution of more than one antibiotic course is not recommended. Uroflowmetry 
may help select patients who might benefit from a specific drug treatment, e.g. σ1-
receptor blockers. Renal sonography and an abdominal X-ray seem of little use in 
the screening of patients with prostatitis syndromes. 
CONCLUSION 
Patients with prostatitis seen by urologists seem to be younger and mostly com­
plain of pain in the perineum, penis or scrotum, while GP's frequently see older 
patients patients with micturition complaints. GP's consider bacterial infection as 
the most important cause, while urologists mention nonbacterial causes. According 
to urologists, psychosomatic causes frequently contribute to chronic prostatitis. 
Although infections cannot be traced, the first-choice treatment consists of 
antibiotics, both groups preferring co-tnmoxazole Sulfatrim, administered over 
about 3 weeks. If not successful, frequently a second course of antibiotics is 
prescribed. The success rate achieved by GP's is higher than that by urologists 
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ABSTRACT 
Psychologic factors have been considered to play an important role in the 
etiology of chronic prostatitis. Earlier studies are often based on a psychoanalytical 
perspective and seldomly used quantitative approaches. In the present study 
quantitative tests are used to investigate personality variables which are suggested 
in the literature as underlying chronic prostatitis. 
A group of 50 chronic prostatitis patients was compared with a group of 50 
patients seen for a vasectomy. Psychologic measures were taken by means of a 
personality inventory (NVM, Dutch Short form of the MMPI), a symptom checklist 
(SLC-90) and a depression inventory (IDD). Results showed statistically significant 
differences between the groups, with the chronic prostatitis patients scoring 
consistently higher on the measures than vasectomy patients. However, these 
differences in scores were not of a great magnitude and minor compared to 
differences in scores from psychiatric patients. Discriminant analysis suggested 
somatization and depression to be the key variables to distinguish chronic prostati-
tis patients from vasectomy patients. Overall, it seemed unfounded to label chronic 
prostatitis patients "neurotic" or "psychopathologie," and it was impossible to 
conclude that there are personality variables that specifically identify the chronic 
prostatitis patients. 
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INTRODUCTION 
Diagnosis of patients with chronic prostatitis is difficult and treatment often is 
unsuccessful [1-3]. As prostatitis denotes a condition of inflammation of the 
prostate, the infectious causes have been extensively studied. Only five to ten 
percent of the patients are found to have a bacterial infection, and the choice of 
treatment in these patients is antibiotics. However, in the patients without an 
infection, antibiotics are also the most frequently advocated treatment [4]. Other 
approaches consist of administration of parasympaticolytic medication, pain 
medication, or even transurethral resection of the prostate. The results of these 
therapies in most cases are disappointing. 
Psychologic factors also have been considered as playing an important role in the 
etiology of prostatitis 15-31). The empirical evidence, examining the correlation 
between possible psychologic factors and chronic prostatitis, stems from a variety 
of theoretical perspectives and offers mixed results. An overview of these perspec-
tives, and the most important findings are summarized in Table 1. 
As early as 1934, Menninger proposed that personality traits are at issue in 
chronic prostatitis [5]. Later Lewin (1960) suggested that "psychological factors 
are suspected of playing an important role in the symptomatology of chronic 
prostatitis and possibly in its etiology" [6]. He based his statement on a critical 
literature review which questioned the criteria for diagnosis and methods of treat-
ment from both clinical and theoretical points of view. 
In general, urology patients as a group tend to exhibit a wide spectrum of 
psychiatric problems [7]. Among urologists, there is a widely held belief that 
"neurotic" patients have many genito-urinary complaints. Psychiatric patients also 
seem to have the same complaints [6,8] In much of the research done, using such 
measures as Rorschach, Thematic Apperception Test (TAT), Minnesota Multiphasic 
Personality Inventory (MMPI), and Beck's Depression Inventory, results were 
interpretated predominantly from a psychoanalytical perspective [8-13]. Within this 
view chronic prostatitis patients often tend to be characterized as having problems 
with their male identity due to improper identification with a father figure [11]. 
Regardless of the theoretical framework used in the different studies, the three 
themes which consistently surface in investigations of potential causes and 
correlates of chronic prostatitis are neuroticism ("prostate-neurosis"), psychosoma-
ticism, and sexual problems. 
Green and Dean [10] described chronic prostatitis patients as suffering from 
"psychoneurosis", while Mellan et al. [14] go even one step further in introducing 
the term "prostate neurosis" for this patient group. According to Janssen et al. [11] 
"neurotic" disorders with symptoms such as anxiety, depression, fear, and feelings 
of insecurity seem to be present in most all prostatitis patients, irrespective of the 
urologie findings. No significant differences are found in psychodynamic or psycho-
logic test examinations between patients suffering from prostatitis caused by an 
infection, or patients with nonorganic prostatitis. 
In a number of studies psychosomatics was found to be an important aspect of 
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Table 1 Literature overview. BDI = Becks Depression Inventory, MMPI = Min­
nesota Multiphasic Personality Inventory, FAM = Finnish version of 
MMPI, TAT = Thematic Apperception Test, NVM = Dutch short form 
of the MMPI, SCL-90 = Symptom Check List, IDD = Inventory to 
Diagnose Depression, CP= chronic prostatitis group, VAS= control 
group 
Series 
Green and Dean (19S4)10 
Janssen et al (1983)" 
Keltikangas et al. (1982)" 
Keltikangas et al. (1984)" 
Keltikangas et al. (1989)" 
Mendlewicz et al (1971)' 
Mellan et al (1972)'4 
Mellan et al (1973)'5 
Miller (1988)25 
Rosenbloom (1955)* 
Theoretical View 
Psychoanalytic 
Psychoanalytic/ 
interactional 
Psychoanalytic 
Psychoanalytic 
Psychoanalytic/ 
behavioral 
Psychoanalytic/ 
psychosomatic 
Personality/ 
psychosexual 
Personality/ 
psychosexual 
Behavioral/stress 
management 
Psychosexual 
development 
Measure 
Clinical observations 
Psychoanalytic interview 
Giessen test 
BDI 
MMPI (FAM) 
TAT 
Rorschach 
Psychoanalytic interview 
TAT 
Rorschach 
Clinical interview 
MMPI 
BDI 
Rorschach 
TAT 
Clinical interview 
Bell inventory 
Rorschach 
Knoblauch-Hausner 
N5 neurolicism questionaire 
Structured interview 
Knoblauch Hausner 
N5 questionnaire 
Leary test 
Clinical interview 
Self report complaints 
Self report "cure" 
Clinical observations 
Finding 
Common symptomatology 
of urology and psychiatry 
patients 
All patients show neurotic 
disorders, irrespective of 
urological findings 
4 personality pathologies. 
poe. correlation between 
durtion, somatic 
symptoms and severity 
of psychologic problems 
Sexual problems deeply 
involved in personality of 
СР patients 
High anxiety, depression, 
weak masculinity; latent 
homosexuality 
Follow-up increase of stress 
anxiety, depression, 
striking sexual problems 
СР patients are anxious, 
asthenic, rather depressed. 
passive and dependent, 
latent homosexual tendencies 
СР should be viewed as 
psychosomatic disorder 
"Prostate neuroses" significant 
correlation between sexual 
disorders, high neurolicism, 
low dominance 
Stress is strong influence on СР; 
stress mgmt helps relieve 
symptoms 
Chronic prostitis is result of 
sexual problems 
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chronic prostatitis 18,13-15]. It was concluded that "psychosomatic" personalities 
generally are highly interested in their bodily functions and seem to express 
psychologic problems and emotions somatically. Therefore, it was argued that 
chronic prostatitis should be viewed as a "psychosomatic" disorder. 
A discussion of sexual problems as they relate to chronic prostatitis is mentioned 
in almost all studies. In a study based on clinical observation, Rosenbloom (16) 
went so far as to argue a direction of causality, concluding that prostatitis was the 
result of sexual problems, and not the other way around. Keltikangas et al. [17] 
suggested that sexual problems of chronic prostatitis patients are deeply rooted in 
their personality structures. In another study Keltikangas et al. [12] reported results 
based on a two-year longitudinal study that showed that chronic prostatitis 
subjects displayed a significant increase in sexual problems. 
Overall, research on patients with chronic prostatitis seems to suggest that 
psychologic problems are a contributing factor to their condition. A failure to 
respond to any given treatment for chronic prostatitis possibly may be the result of 
psychosomatic or psychoneurotic conditions in these patients. The present study 
attempts to shed some light on the aforementioned belief by comparing test scores 
of a personality inventory (NVM, the Dutch Short form of the MMPI), a symptom 
checklist (SLC-90) and a depression inventory (IDD), between a group of chronic 
prostatitis patients and a control group of patients seen for vasectomy. The test 
results of both groups are compared with the test norms for "normal", cardiac 
outpatients, and psychiatric outpatients. 
METHOD 
Subjects: From June through October 1991, 50 patients with chronic prostatitis 
(CP) and 50 patients seen for a vasectomy (VAS), participated in this study. 
Patients were recruited from the outpatient department of the Department of 
Urology of the Canisius Wilhelmina Hospital and the University Hospital Nijmegen. 
Inclusion criteria for the CP patients were the following: (1) patients must have 
complaints of a chronic prostatitis nature (irritative bladder symptoms and/or pain in 
the genitourinary region), (2) patients have had symptoms for at least six consecuti-
ve months without response to any given therapy, (3) patients did not have 
bacteria in the semen and/or the prostatic fluid culture, and (4) patients had to be 
between 20 and 60 years old Furthermore, we evaluated the outcome of the 
numbers of white blood cells in the prostate fluid. The control group (VAS) in the 
study consisted of 50 men, who consulted the department of urology for a 
vasectomy. To be included in this group, patients should not have had complaints 
related to prostatitis and the age of the patients also had to be between 20 and 60 
years. While subjects were selected on a nonprobability, judgemental procedure, 
efforts were made to match the subjects in both groups on their demographic 
profiles, based on age, education, occupation, and marital status. 
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Measurements: After urologie screening, all psychologic tests were administered 
by the same researcher at the Department of Clinical Psychology, Canisius Wilhel-
mina Hospital Both groups underwent three tests; the SCL-90, the NVM, and the 
IDD. 
The "Symptom Checklist" (SCL-90) [18] is a multidimensional self-report inven­
tory, based on the American SCL-90-R. This test provides an estimate of the 
psychologic problems experienced by the patient across eight dimensions: anxiety, 
agoraphobia, depression, somatisation, interpersonal sensitivity, insufficiency of 
thought and action, sleeping problems, and hostility. There is an additional overall 
measure for psychoneuroticism, reflecting psycho-neuro-somatic distress. This 
checklist is a reliable and valid instrument and the English version is widely used as 
a psychiatric screening instrument for inpatient and outpatient populations For the 
Dutch population there are norms available for various groups: 'normal' (n = 432), 
psychiatric outpatients (n=1044), and cardiologie outpatients (n = 55). It takes 15-
20 minutes to complete this checklist. 
The "Dutch Short Form of the ΜΜΡΓ (NVM) [19] was used in addition to the 
SCL-90 and this test measures, negativism, somatisation, embaressment, psycho-
pathology, and extraversion. Norms are available for the following groups: 'normal' 
(n = 894), psychiatric outpatients (n = 297), and patients with psychosomatic com­
plaints (n = 455) It takes 15-20 minutes to complete this questionnaire. 
Finally, the "Inventory to Diagnose Depression" (IDD) [20,21] was used to 
measure a variety of depression symptoms and is generally used to diagnose the 
DSM-III-R classification "major depressive episode" and "melancholia" in special 
patient populations and in normal subjects. The IDD proved to be a reliable and 
valid instrument for the Dutch population. It takes 15-20 minutes to complete this 
questionnaire. 
In addition, the chronic prostatitis group was also asked whether or not (1) they 
had been treated by other specialists in the past for their condition, (2) they had 
been treated by a psychiatrist or psychologist, and (3) they would want to be 
treated by psychiatrist in relation to their prostatitis condition. 
Design and Procedures: After receiving permission from the Medical Ethical 
Committee, the recruitment of patients began. Following the medicai/urologie 
screening, all patients in the chronic prostatitis group were approached by the 
urologist, extensively informed about the purpose of this study, and then participa­
tion was elicited Patients participated voluntarily and gave their informed consent 
The medicai/urologie tests were done by one urologist. All three psychologic test 
were administered to the subjects in one sitting by the same researcher at the 
Clinical Psychology Department, Canisius Wilhelmina Hospital. Subjects were given 
the opportunity to discuss the tests after completion or at any later date if they so 
desired. 
The group of vasectomy patients also was screened medically/urologically, 
informed about the study, and requested to participate by the urologist. All data 
collection for all subjects took place in the period June through October 1991. 
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Data analysis 
Between group analysis The data were analysed by means of chi-square analysis 
and t test. In addition, a two-group discriminant analysis, which specified a model 
using demographic variables and all psychological variables that were significantly 
different in the t test, was performed to provide a multivariate analysis of the 
differences between the two groups. 
Within group analyses: To more closely investigate the possible relationship of 
chronic prostatitis problems with both demographic and psychological measures, 
the group of chronic prostatitis patients were split into smaller, more homogeneous 
groups. Three levels of analyses were based on: (1) duration of chronic prostatitis 
problems: group with 30 months or less (n = 24), or more than 30 months (n = 26); 
(2) type of complaint: groups of either micturition complaints (n = 24) or pain 
problems (n = 26); (3) number of complaints: 2 or less, and more than 2, based on 
the median split Chi-square analysis and t test were performed to compare these 
empirically formed groups. 
Because the results of the data analysis were irrespective of the numbers of 
white blood cells in the prostate fluid, we didn't present results of the subgroups 
(prostatodynia and non bacterial prostatitis group). 
RESULTS 
Demographic and Behavioral Measures: The age of the CP patients ranged from 
22 to 54 years (average, 40 years) and from 28 to 62 years (average, 39 years) in 
the VAS group. Matching education, occupation, and marital status, between the 
CP and VAS groups proved to be successful (t test and x2 all > 0 10). The patients 
were predominantly middle class in terms of their education (84%) and occupatio-
nal status (69%), and 9 1 % of all patients were married or living with a steady 
partner. Within the CP group, the average duration of symptoms was approximately 
40 months, with a mean and median of two complaints per patient. Forty-one of 
the patients (82%) had not been treated by another specialist. Only two patients 
(4%) had been treated by a psychiatrist or a psychologist. Regarding the question 
of whether or not they want to receive psychologic counseling, 36 patients (72%) 
saw absolutely no reason for seeking psychologic help concerning their chronic 
prostatitis condition. 
Between Group Comparisons: Of the five dimensions measured by the NVM, only 
the Somatization scale produced a significant difference between the two groups 
( t (98)=3.81, p<0.01), with CP patients scoring significantly higher on this scale 
than the VAS group. There were more pronounced differences between the two 
groups on the SCL-90. Significant differences were found on anxiety, depression, 
somatic complaints, sensitivity, sleeping problems and psychoneuroticism. These 
scores were consistently higher for the CP group. 
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Figures 1 and 2 plot the scores of the NVM and SCL-90. Finally, results of IDD 
showed that the CP group scored significantly higher on this test than the VAS 
group. Table 2 gives an overview of the t test results of all psychologic measures 
between the two groups. 
Figure 1 NVM (Dutch short form of the Minnesota Multiphasic Personality 
Inventory) scores for the group with chronic prostatitis (CP) and the 
control group (VAS). Neg = negativism, Som=somatisation, 
Shy = shyness,Psy = psychopathology. Ex = extraversion. 
> 
ζ 
-G- Group VAS 
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Figure 2 Symptom Check List (SCL-90) scores for group with chronic prosta­
titis (CP) and the control group (VAS). anx = Anxiety, Ago = agorap­
hobia. Dep = depression. Som = somatic complaints. Ins = insuffi­
ciency of thought & action. Sens = interpersonal sensitivity, 
Hos = hostility, Sleep = sleeping problems. 
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Table 2 t test results of psychological variables between group with chronic 
prostatitis (CP) and the control group (VAS). NVM = Dutch short 
form of the MMPI, SCL = Symptom Check List, IDD = Inventory to 
Diagnose Depression. 
Variable/Group Mean SD t-value 
NVM Negativism 
CP 
VAS 
NVM Somatization 
CP 
VAS 
NVM Shyness 
CP 
VAS 
NVM Psychopathology 
CP 
VAS 
NVM Extraversion 
CP 
VAS 
SCL Anxiety 
CP 
VAS 
SCL Agoraphobia 
CP 
VAS 
SCL Depression 
CP 
VAS 
SCL Somatic complaints 
CP 
VAS 
SCL Insufficiency of thought and action 
CP 
VAS 
SCL Interpersonal sensitivity 
CP 
VAS 
SCL Hostility 
CP 
VAS 
SCL Sleeping problems 
CP 
VAS 
SCL Psychoneurotocism 
CP 
VAS 
IDD Depression 
CP 
VAS 
13.38 
13.72 
9.68 
4.28 
9.44 
8.94 
1.66 
1.74 
13.78 
15.08 
13.94 
11.36 
7.60 
7.50 
22 
18.92 
18.24 
14.60 
13.88 
11.64 
22.60 
21.90 
7.60 
6.86 
5.06 
3.98 
123.36 
106.62 
10.94 
5.18 
7.42 
5.46 
8.45 
5.38 
7.34 
6.10 
1.64 
1.89 
5.96 
4.96 
4.71 
1.88 
1.43 
1.25 
7.20 
4.27 
6.34 
3.75 
5.45 
2.83 
5.63 
4.20 
2.35 
1.39 
2.92 
1.82 
32.31 
16.95 
9.14 
6.21 
-0.26 
3.81 
0.37 
-0.23 
-1.15 
3.60 
0.37 
2.60 
3.5 
2.58 
1.71 
1.92 
2.22 
3.24 
3.68 
0.795 
0.0001 
0.712 
0.822 
0.253 
0.001 
0.71 
0.011 
0.001 
0.012 
0.090 
0.058 
0.029 
0.002 
0.0001 
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To develop a clearer assessment of which psychologic measures best discrimi-
nate between the two groups, the different psychologic measures were considered 
simultaneously. Using a step-wise approach, none of the demographic variables 
entered as significant in the discrimimant model. Two psychologic variables, the 
NVM Somatization dimension and the IDD, were able to produce a significant 
discriminant function (Wilks's lambda = 0.856: Chi-square= 15,07, p< 0.001). 
These two variables alone were able to correctly group membership of the CP or 
VAS patients 67 percent of the time. While this prediction rate is significantly 
better than chance, the discriminant function was best able to predict the VAS 
patients (82% correctly predicted) and only 52 percent of the CP patients were 
correctly predicted (Table 3). 
Table 3 Classification Matrix of two-group discriminant analysis. 
CP = chronic prostatitis group, VAS = control group. 
Predicted Group Membership 
Actual Group No. of Cases CP VAS 
CP 50 26 (52%) 24 (48%) 
VAS 50 9 (18%) 41 (82%) 
To better understand the basis for misclassification of the CP patients, the two 
groups formed by the discriminant analysis on the CP patients only were compared 
on demographic, behavioral and psychological measures. One group of CP patients 
was based on the correctly predicted CP patients from the discriminant analysis 
(n = 26), and the other group was formed by chronic prostatitis patients who were 
misclassified as VAS patients (n = 24). In terms of demographic profile, the only 
difference between these two groups was level of education, with the misclassified 
subjects being more than twice as likely to have attained higher levels of education 
than the correctly classified group (x2(26,6) = 8.18, p<0.05). Otherwise, age, 
marital status, and number of children were nonsignificant, as were measures of 
duration of complaints, number of complaints, type of complaints, or treatment 
histories. Univariate F tests between classified and misclassified CP patients offered 
an additional profile on these patients: IDD, NVM Somatisation, and SCL-90 
Depression were the three variables with the greatest degree of differences, 
followed by SCL Neuroticism. 
These post hoc results, taken together with the results of the discriminant 
analysis between the CP patients and VAS patients, which used only IDD and NVM 
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Somatization measures to develop a highly significant function, suggest that 
somatization and depression are the key psychologic variables which distinguish the 
CP subjects from the VAS subjects in this study. 
Duration, Incidence, and Type of Symptoms among CP Patients: While there was 
no significant correlation between the number and duration of the symptoms, the 
results showed that the number of symptoms correlated positively with the SCL-90 
anxiety scale (r = 0.29, p<0.05). Furthermore, the duration of the symptoms, 
operationahzed as the number of months the subject has had the symptoms 
correlated significantly with sleeping problems (r = 0 39, p<0.01). Using the 
median split of 30 months to divide the CP group into more homogeneous groups 
based on duration of symptoms offered one additional insight, the group having had 
prostatitis problems the longest was three times as likely to have been treated by 
another medical specialist. Finally, dividing the subjects into groups based on the 
type of symptoms (i.e., micturition or pain), showed that patients in the "pain" 
group scored significantly higher on the NVM Psychopathology Scale (t(48) = 2.12, 
p<0.03). 
DISCUSSION 
The theoretical framework most often used in the research in chronic prostatitis 
patients has a strong psychoanalytical basis, and the body of empirical evidence 
often suggests that a failure to respond to any given treatment for chronic prostati-
tis is apparently the result of abnormally high psychosomatic or psychoneurotic 
conditions in these patients [8,13,15] Furthermore, most research to date has 
studied personality variables only within the prostatitis population, using the nature 
of the symptoms (bacterial or nonbacterial infection) or duration of the symptoms 
(curability) as criteria for comparison. 
This study compared two patient groups of men who were well matched on 
demographic profiles, and found significant differences between the groups on 
eight out of the fifteen psychologic variables (Table 2). All differences were 
consistently higher for the CP group. While these differences were statistically 
significant, the differences were not of a great magnitude (Fig 1 and 2). This result 
does support the findings of other studies; however, it does not support the 
severity of personality problems described in other studies 
Apart from the t test for differences on the variables, the two-group discriminant 
analysis produced a highly significant function using only two variables, the NVM 
Somatisation scale and the IDD. Results of the discriminant analyses and subse-
quent post hoc analyses of the groups of CP patients, who were either correctly or 
incorrectly predicted as being CP patients based on the discriminant function, 
would suggest that depression or somatization are the two best variables to 
discriminate between groups. 
The NVM Somatization scale contains items that relate to a variety of vague 
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physical complaints. High scores on this scale indicate that one reacts to psycholo-
gic stress with physical complaints. However, for people with actual physical 
disease, high scores here do not indicate a tendency to somatization. The same 
holds true for the somatic complaints dimension of the SCL-90, and a warning is 
given in case of elevated scores, never to exclude the possibility of actual physical 
complaints. Cavanaugh et al. reported, that somatic symptoms were reported 
substantially more often by the medically ill than by normal subjects [22]. However 
in several other studies it is stated that "psychosomatic" personalities generally are 
highly interested in their bodily functions and seem to express psychologic pro-
blems and emotions somatically [8,13,15,23]. Therefore they argued that chronic 
prostatitis should be viewed as a "psychosomatic" disorder. From the results in this 
study it is impossible to draw the conclusion, that chronic prostatitis is the physical 
response to psychologic stress. As mentioned earlier, chronic prostatitis is a 
condition that presents itself with a variety of symptoms. A plausible explanation 
for the elevated somatization scores could well be the fact that the CP patients in 
this study all reported at least one physical complaint (mean and median being two 
complaints) related to their chronic prostatitis condition that had a serious impact 
on their physical well-being. This conclusion is supported by the fact that cardiolo-
gie outpatients, for which patient group norms are available on the SCL-90, showed 
the same profile on this test as CP patients did. Apparently this particular profile on 
the symptom checklist is not exclusive to chronic prostatitis patients. The question 
raised here is whether or not this also could be the case for different outpatient 
populations in physical distress. Elevated scores on this test may well have a close 
link to (m)any physical disorders. 
The somatic symptoms commonly used to diagnose depression also may result 
from medical illness. The stress of physical illness may result in mild, grieflike 
symptoms [22]. The depression scale administered in this study (IDD) is an instru-
ment specifically capable of measuring depression. It is specific in the sense that it 
meets all the DSM-III-R criteria to diagnose a "major depressive episode" and does 
not measure anything else [24]. There is a low correlation between the IDD and 
other scales that measure anxiety and neuroticism, which is not the case in some 
other depression inventories often used in clinical populations [25,26]. The IDD is 
also a measure that is able to quantify the severity of the depression [27]. In spite 
of the fact that the IDD turned out to be one of the two best discriminating 
variables between the CP and VAS patients in this study, none of the patients 
reached the cut-off score above which they would be diagnosed as suffering from a 
depression according to the DSM-III-R However, patients with prostatitis frequently 
present themselves with pain complaints. Furthermore, there seems to be a higher 
incidence of clinical depression and depressive spectrum disorders in patients with 
chronic pain than in control subjects [28,29] Therefore, it is suggested that 
individuals prone to have pain may manifest pain as a depressive equivalent, 
resulting in a complex relationship between pain and depression [30]. These 
patients, when questioned will often deny any depressive symptoms and blame 
everything on pain Some of these patients, however, seem to respond favorably to 
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antidepressive therapy [31]. 
The theoretical and empirical discussions found in the literature often tend to 
leave the impression that chronic prostatitis patients resemble the psychiatric 
population, suffering severe disturbances in this area [13]. Green and Dean [10] 
described chronic prostatitis patients as suffering from "psychoneuroses" while 
Mellan et al. [15] go one step further by introducing the term "prostateneuroses" 
for this group of patients. Also, Jansen et al. [11] found that "neurotic" disorders 
with symptoms such as anxiety, depression, fear and feelings of insecurity seem to 
be present in most patients with prostatitis complaints, irrespective of the urologi-
cal findings. The test results of the present study suggest that this characterization 
is unfounded. For both the NVM as well as for the SCL-90 there are norms 
available for psychiatric patient populations. The significant differences between CP 
patients and VAS patients on all variables turned out to be minor compared with 
the differences from psychiatric patients (Figs 3 and 4). 
Psychologic factors are involved in all diseases, not only in a certain group of 
diseases. Therefore it is most difficult from the results of the present study, to 
arrive at the conclusion that there are personality variables that can specifically 
identify the chronic prostatitis patient. It seems unjustified and unfair to this group 
of patients to be labelled "neurotic" or to be identified as having a "psychopatholo-
gie" condition. The question comes to mind of whether or not an idiographic 
approach to research personality variables underlying chronic prostatitis would not 
do more justice to the individual patient in terms of diagnosing his condition, and 
provide a more differential picture of personality variables involved in each patient. 
However, the test results do show significant differences on somatization and 
depression for the chronic prostatitis patients. These elevated scores may be 
caused by the physical complaints related to their chronic prostatitis. But, it is also 
suggested that some patients with this condition, and predominately presenting 
with pain complaints, may improve on a trial of low dose antidepressants. 
Acknowledgement: To G.J. Bamossy, PhD, Free University at Amsterdam for his 
statistical analysis. 
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Figure 3 NVM (Dutch short form of the Minnesota Multiphasic Personality 
Inventory) scores for group with chronic prostatitis (CP), control 
group (VAS) and psychiatric patients. Neg = negativism, 
Som = somatisation, Shy = shyness, Psy = psychopathology, 
Ex = extraversion. 
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Figure 4 Symptom Check List (SCL-90) scores for group with chronic prosta­
titis (CP), control group (CP) and psychiatric patients. Anx = anxiety. 
Ago = agoraphobia. Dep = depression. Som = somatic Complaints, 
Ins = insufficiency of thought & action. Sens = interpersonal sensi­
tivity, Hos = hostility. Sleep = sleeping problems. 
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ABSTRACT 
We reviewed the results of the urine cytology examination of 206 patients with a 
diagnosis of prostatitis syndromes in the period 1985-1991. The urine samples 
showed an incidence of 20,4 percent of slight-to-moderate atypia and of 6,3 
percent for severe atypia. In these patients, cystoscopy, bladder biopsies and 
intravenous urography were performed to exclude malignancies. Only in 6 of the 13 
patients with severe atypia of the urine cytology were malignancies found. In cases 
of malignancy, the ages of the patients ranged from 51 to 64 years (mean, 58.6 
years), and they complained most frequently of irritative bladder symptoms. In 
these patients, urine analysis frequently showed leucocytuna, and in all samples, 
erythrocytuna was found. 
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INTRODUCTION 
Prostatitis is inflammation of the prostate. Although the term implies an infecti-
ous disease, serious doubt exists as to the infectious origin of the condition in some 
cases. Typical complaints of patients with prostatitis syndromes are pain in the 
lower abdomen and/or genital area and urinary symptoms. 
Interstitial cystitis, carcinoma-in-situ and invasive bladder tumors may cause 
complaints similar to those of prostatitis and should be ruled out with urine 
cytology and cystoscopy. If necessary, a bladder biopsy and an IVU should be 
performed. Although recommended in the literature, no exact data are available 
concerning the value of urine cytology in the screening of patients with prostatitis 
syndromes. 
This retrospective study was done to evaluate the diagnostic value of urine 
cytology for the diagnosis of malignancies of the urinary tract in patients with 
prostatitis syndromes Also, the results of urine sediment analysis, urine culture and 
treatment in these patients were reviewed. 
MATERIALS AND METHODS 
Urine samples for cytology were collected from 206 patients during the period 
1985-1991. All patients presented with prostatitis syndromes. 
In this retrospective study the following parameters were analyzed: age, duration 
of complaints, kind of complaints, urine analysis, urine cytology, IVU, results of 
cystoscopy and biopsies, result of treatment. 
RESULTS 
Urine cytology was performed in 206 patients with complaints of prostatitis. In 
65.5% no abnormalities were found, signs of infection in 7.8% and slight-to-
moderate atypia in 20.4%. In the patients with a slight-to-moderate atypia, 
malignancy was excluded by UCS, bladder biopsies and an IVU. In 13 patients 
(6,3%) severe atypia was seen. In cases of severe atypia, carcinoma-in-situ and/or 
invasive bladder tumor was found in 6 patients (Table 1). 
Evaluation revealed no signs of malignancies in 200 patients. In these patients 
the age ranged from 20 to 85 years (mean, 45 years). The complaints were pain, 
irritative bladder symptoms, urethral discharge, haematospermia and haematuna 
(Table 2). Most patients (44,5%) had had their symptoms for less than 6 months 
and 24 patients (12%) had had complaints for at least 5 years. In these patients, 
urine analysis showed no abnormalities in 62.5% of the samples, 0-5 erythrocytes 
per high power field in 22.5% and more than 5 erythrocytes per high power field in 
15%. In 63.5% of the urine samples no leucocytes were found and, in 27.5% and 
9%, respectively, 0-10 and more than 10 were found. 
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In the six patients in whom malignancies were found, the ages ranged from 51 to 
64 years (mean, 58.6 years). These patients most frequently complained about 
irritative bladder symptoms (Table 2). The duration of complaints is presented in 
Table 1. Urine analysis showed erythrocyturia in all patients, zero to five erythrocy­
tes per high power field in one patient and more than five erythrocytes per high 
power field in five patients. Two patients had no leucocyturia, three patients had Ο­
ΙΟ leucocytes, and one had more than 10 leucocytes per high power field. The 
seven patients with severe atypia and no carcinoma continued to shed these 
abnormal cells in another two to three samples. After some months the urine 
cytology normalized: in three cases after antibiotic treatment, in two after treat­
ment for urolithiasis and in two spontaneously. 
Except for urolithiasis in three patients, no abnormalities were seen on IVU in 
these 206 patients. In three patients with urolithiasis, prostatitis was seen in 
combination with the urolithiasis. In these patients, the symptoms of prostatitis 
seemed unrelated to the urolithiasis. 
Table 1 Diagnosis and treatment of malignancies 
No Age Duration Diagnosis Treatment 
51 9 months pt lgl l l cystoprostatourethrectomy 
and CIS and Bricker derivation 
2 
3 
62 5 years CIS 
5 
6 
63 
64 
58 
54 
10 years 
1 month 
3 months 
1 year 
pt lgl l l 
and CIS 
pt2glll 
and CIS 
pt lgl lb 
pt2glll 
and CIS 
BCG bladder instillations 
cystoprostatourethrectomy 
and Bricker derivation 
cystoprostatectomy and 
Hautman bladder replace­
ment 
BCG bladder instillations 
cystoprostatourethrectomy 
and Bricker derivation 
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Table 2 Symptoms in patients with prostatitis syndromes (n = 200) and with 
malignancies (n = 6). 
Complaints 
Pain 
-Penoscrotal pain 
-Suprapubic pain 
-Perineal pain 
-Pain in groins 
-Backpain 
-Pain during ejaculation 
Irritative bladder symptoms 
-Frequency 
-Stranguria 
-Dribbling 
-Dysuria 
-Hesitation 
Other symptoms 
-Urethral discharge 
-Haematospermia 
-Haematuna 
Prostatitis 
(no of cases! 
93 
80 
47 
40 
29 
17 
98 
78 
78 
32 
33 
20 
13 
11 
Malignancy 
(no of cases) 
2 
2 
1 
0 
0 
0 
3 
5 
3 
2 
1 
0 
0 
2 
DISCUSSION 
Although prostatitis syndromes appear to be some of the most common patholo-
gic conditions encountered in urology, a number of questions have yet to be 
answered concerning their diagnosis and treatment. Generally, cytologic urine 
screening is recommended but no exact data are available concerning the validity of 
this investigation. To our knowledge, this is the first study with regard to this 
subiect. 
In this study the main complaints appeared to be pain and irritative bladder symp-
toms for the prostatitis patients and mainly irritative bladder symptoms for the 
patients with malignancy Because of the causative agents, the reasons seem clear. 
We found that in three of the six patients with malignancy, the duration of symp-
toms was one, five and ten years respectively. Because the finding of clearly 
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malignant cells in urine samples calls for further investigations, we think that in 
these patients proper therapy could have been initiated earlier if urine samples for 
cytology would have been obtained. Perhaps this could have prevented (mutilating) 
surgical treatment. However another study of ours showed that only by 35 percent 
of the Dutch urologists perform cytologic examinations of urine samples in patients 
with prostatitis syndromes [2]. 
Erythrocytuna was found frequently in the prostatitis patients and always in 
patients with malignancy. In cases of slight to moderate atypia on urine cytology, 
no signs of malignancy were encountered. Because of this finding, the merits of 
screening such patients with cystoscopy and IVU are questionable. Only m case of 
concommitant sterile leucocytuna and/or haematuna and mainly irritative bladder 
symptoms this type of screening is recommended. Furthermore, we should focus 
our screening on older patients because this study showed that malignancies only 
occurred in patients older than 50. However, we recognize that malignancies may 
also occur in younger patients and thus age should not be chosen as a criterion for 
exclusion of malignancy. 
Finally two questions remain to be answered: How reliable is cytologic screening 
in patients with prostatitis syndromes and how many urine samples should be 
obtained to exclude malignancies? According to Esposti and Zajicek (1972) [3], in 
experienced hands carcinoma of the bladder, grade II or above, was accurately 
identified in 78 per cent of cases. For high grade tumors the diagnostic accuracy 
reached the level of 91 per cent Morse and Melamed (1974)14] pointed out that 
the shedding of cancer cells in urine is extremely variable Therefore, three or more 
specimens must be examined in each patient. Also Beyer-Boon ( 1977)[1 ] recorded 
a significant improvement in the cytologic diagnosis when using multiple urine 
samples. In this study we found that only in patients with severe atypia were 
malignancies found, and therefore we may rely on this kind of screening to exclude 
malignancies. Interpretation of urine cytology varies between institutions, and the 
reliability of the results depends on the judiciousness and experience of the investi-
gator. Whether one urine sample for cytologic screening in these patients is 
sufficient to exclude malignancies remains to be answered. We recommend, in case 
of doubt, repeating the urine cytology. In patients with prostatitis syndromes, with 
severe atypia without carcinoma, a severe urinary tract infection or urolithiasis can 
cause the symptoms 
Urine cytology should allways be performed on patients with prostatitis syndro-
mes. In this study severe atypia was found in 6,3% of urine samples, and malig-
nancies were found in almost 50% of these patients. However, the value of the 
outcome of cytologic screening in patients with prostatitis syndromes is dependent 
on the judiciousness and experience of the investigator. 
Acknowledgements: We thank the department of pathology for the use of the 
PALGA data system. 
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ABSTRACT 
The potential value of prostatic imaging in the diagnosis of inflammatory disor-
ders of the prostate is largely unexplored. In several studies, specific ultrasono-
graphic characteristics in patients with prostatitis have been described. Also non-
specific echogenic qualities in prostatitis have been pointed out. To evaluate ultra-
sound of the prostate in patients with nonbacterial prostatitis in this study, ultra-
sound images of these patients were compared with those of a healthy control 
group. In contrast with earlier findings, constant dilatation of the periprostatic 
venous plexus was seen more pronounced in the control group as well as elong-
ation of the seminal vesicles. Finally, prostatic calcifications were frequently 
encountered in both groups. 
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INTRODUCTION 
The diagnostic classification in prostatitis is based on the complex clinical and 
pathologic assessment proposed by Meares and Stamey [1]. The majority of 
patients with prostatitic complaints have no clinical evidence of an inflammatory 
process within their prostates or lower urinary tract. Therefore, they are said to 
have prostatodynia or nonbacterial prostatitis. Thus, other methods are needed to 
delineate this group of patients with so called prostatitis. 
However, still to be established as a decisive method in the diagnosis prostatitis, 
prostatic ultrasound can be supposed to offer a substantial contribution. To be of 
potential value, it should give urologists additional information that cannot be 
obtained by conventional diagnostic methods. 
Several authors have described characteristic ultrasound features in patients with 
bacterial and nonbacterial prostatitis [2,3]. Also, one can distinguish echogenic 
differences which are not specific for this prostatic disease [4,5]. Because of these 
contradictions, we conducted a study in which the echographic images of the 
prostate in patients with nonbacterial prostatitis were compared with those of a 
control group without complaints related to the prostate. We decided to evaluate 
patients with nonbacterial prostatitis because of the high incidence of this disease, 
the difficulty of diagnosis and the difficulty in establishing an objective response to 
given treatment. 
MATERIAL AND METHODS 
Twenty-two patients, aged 21-56 years (mean 41), with non-bacterial prostatitis, 
and 22 patients, aged 25-43 years (mean 35), without any complaints, underwent 
transrectal ultrasound scanning. The diagnosis of nonbacterial prostatitis was 
reserved for those patients with symptoms localized in the prostate (e.g. pain in the 
perineum, suprapubic area, testicles, groin, the flank or at ejaculation), without 
bacteria in the expressed prostatic secretion but with evident leucospermia. 
The ultrasound scanner of Brüel and Kjaer, type 1846, with a 7-MHz transrectal 
probe 1850 was used. This probe was clamped into a stand, and serial transverse 
scans of the prostate were obtained from base to apex. Of each prostatic section 
thus obtained, the outline was defined. The area of each transverse section was 
calculated with an electronic planimeter connected to a computer, which also 
calculated the total volume expressed in cubic centimetres. Also, the image with 
the largest area of the plexus of Santorini was visualized. With the pencil-follower, 
as used for the volume measurement, the area of the plexus was calculated and 
expressed in square millimetres. Finally, the image of the prostate was evaluated 
with respect to echotexture, calcifications and elongation of the seminal vesicles. 
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RESULTS 
The average volume of the prostate in patients with nonbacterial prostatitis was 
21,4 cm3 (14,6 - 35). In these patients, the plexus of Santorini measured 0 - 350 
mm2 (average 135). 
In the control group, the average volume of the prostate measured 21,2 cm3 (14 
- 32,5) while the plexus of Santorine measured 20 - 470 mm2 (average 185). 
In patients suffering from prostatitis, 10 showed calcifications in the prostate, 
compared to 7 patients in the control group. Hypoechogenicity was seen in 5 
patients with prostatitis and in 2 patients of the control group. Finally, in 2 patients 
with prostatitis, the seminal vesicles appeared elongated, compared to 7 patients in 
the control group (table 1). 
Table 1 Results of ultrasound scanning of the prostate in patients with non-
bacterial prostatitis (n = 22) and a matched control group (n = 22). 
items non-bacterial prostatitis control group 
volume of prostate 
venous plexus 
calcifications 
hypoechogenicity 
"elongated" vesicles 
21,4 cm3 
135 mm2 
10 patients 
5 patients 
2 patients 
21,2 cm3 
185 mm2 
7 patients 
2 patients 
7 patients 
DISCUSSION 
Di Trepani et al.[2] attempted to determine whether it is possible to demonstrate 
characteristic ultrasonographic pictures in patients with chronic bacterial and 
nonbacterial prostatitis. Characteristic ultrasonographic patterns could be obtained, 
consisting of dyshomogeneous echostructure of the prostate, constant dilatation of 
the periprostatic venous plexus, elongated seminal vesicles an thickening of the 
inner septa [2]. 
Another study by Peeling and Griffiths [5] identified 2 other ultrasound features 
which were frequently present in patients with bacterial prostatitis: heterogene-
ousity of the echopattern and prostatitic calculi [5]. In a cadaver study by Hendrikx 
et al.[6] hypoechogenity and also stone formation was found in patients with 
prostatitis. In this study, stone formation was frequently noticed both in patients 
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Figure 1 Ultrasound images of the prostate seen in patients of the control 
group, a.Smaller prostatic calcifications.b.Larger prostatic calcifica-
tions. c.Nonelongated seminal vesicles.d.Elongated seminal vesi-
cles, e.No dilatation of the periprostatic venous plexus.f.Dilatation of 
the periprostatic venous plexus. 
r/V . *&, ^  
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ce with those of Frentzel-Beyme et al.[4] who stated that calcifications are present 
in all prostates of men older than 30 years, and therefore, are not characteristic of 
a pathological entity. Harada et al.[7] conclude that the presence of larger and 
smaller stones is not related to a specific prostate disease either. 
Doble and Carter [3] stated that a combination of characteristics is needed to 
consider the diagnosis of prostatitis. However, ultrasound findings appeared not 
sufficiently specific to differentiate between clinical groups as defined by micro­
scopic analysis of the prostatic secrection. They also found that, for assessing the 
response of the gland to treatment, the only ultrasound feature worthy of follow-up 
was the echolucent zone, presumably caused by edema within the gland 
Finally, some authors found that after treatment, inflamed prostates may 
decrease in size, and reduce to the dimensions and ultrasonic feature of normal 
prostates [5,8]. 
In summary various ultrasonographic patterns have been described in patients 
with a chronic prostatitis syndrome: dyshomogeneous echostructure, constant 
dilatation of the реп-prostatic venous plexus, elongated seminal vesicles, thickening 
of the inner septa, prostatic calculi or an echolucent zone. These findings are in 
contradiction with our findings In patients with nonbacterial prostatitis there was 
no significant difference in echostructure in comparison to the control group. 
Constant dilatation of the periprostatic venous plexus was seen more pronounced 
in the control group as well as elongation of the seminal vesicles. 
Finally, thickening of the inner septa or an echolucent zone could not be noticed, 
and prostatic calculi were seen frequently in both groups. 
Although many abnormalities are present in the sonograms of patients with 
prostatitis or related symptomatology, nonbacterial prostatitis cannot be diagnosed 
with certainty by transrectal ultrasound. We agree with Doble and Carter [3] that a 
combination of signs is needed to consider the diagnosis of prostatitis although no 
characteristic ultrasonographic patterns were found in patients with nonbacterial 
prostatitis. We also agree with them that, if special features are seen, ultrasound of 
the prostate may be used for assessing the response of the gland to treatment In 
contrast with findings of others, in this study, constant dilatation of the peri­
prostatic venous plexus as well as elongation of the seminal vesicles was seen 
more pronounced in the control group. These features seem to be a variation of a 
normal image of the prostate and may be a small реп-prostatic venous plexus, and 
contracted seminal vesicles are typical for nonbacterial prostatitis. Calcifications 
were frequently seen in both groups and also do not seem specific for prostatitis. 
Finally, we may also state that a normal ultrasound scan does not exclude the diag­
nosis of nonbacterial prostatitis. 
Ultrasonographic findings 83 
REFERENCES 
1. Meares EM and Stamey TA: Bacteriologie localization patterns in bacterial 
prostatitis and urethritis. Invest Urol 1968;5:492. 
2 Di Trapani D, Pavone С, Serretta V et al: Chronic Prostatitis and Prosta-
todynia: Ultrasonographic Alterations of the Prostate, Bladder Neck, 
Seminal Vesicles and Periprostatic Venous Plexus. Eur Urol 1988:15:230. 
3. Doble A and Carter SStC: Ultrasonographic findings in Prostatitis. Urol Clin 
of North America 1989;no 4:763. 
4. Frentzel-Beyme B, Schwarz J, Aurich B: Das Bild des Prostata adenoms und 
-karzinoms bei der transrektalen Sonographie. Fortschr Ròntgenstr 
1982;137: 261 . 
5. Peeling WB and Griffiths GJ: Imaging of the prostate by ultrasound. J Urol 
1984; 132:217. 
6. Hendnkx AJM, de la Rosette JJMCH, van Helvoort-van Dommelen CAM et 
al: Histological analysis of ultrasonic images of the prostate: an accurate 
technique. Ultrasound in Med & Biol 1990;7:667. 
7 Harada K, Tanahishi Y, Digan D et al: Clinical evaluation of inside echo 
patterns in gray scale prostatic echography. J Urol 1980:124:216. 
8 Clements/Glaslyn R and Griffiths J- Prostatic ultrasound. Br J Hospital 
Medicine 1987:38:549. 

Chapter 8 
AUTOMATED ANALYSIS AND INTERPRETATION OF TRANSRECTAL 
ULTRASONOGRPAHY IMAGES IN PATIENTS WITH PROSTATITIS 
J.J.M.C.H. de la Rosette, R.J.B. Giesen, A.L. Huynen, R.G. Aarnink, M.P. van Iersel, 
F.M.J. Debruyne, H. Wijkstra. 
submitted 
86 Chapter 8 
ABSTRACT 
Transrectal ultrasound (TRUS) offers a valuable complement to digital rectal 
examination (ORE) in diagnosing prostate diseases. However, in case of prostatitis 
syndromes, contradictions are found with regard to characteristic ultrasound featu-
res in these patients. Therefore we sought for better imaging techniques. This 
paper describes a study on the automated analysis of ultrasonographic prostate 
images. With ¡mage processing, in the present study tissue characterisation ¡s per-
formed to predict the probability of the presence of inflammated prostate tissue. In 
patients with prostate cancer this technique already proved its validity. 
During prostate examinations, images were recorded with clear indication of the 
puncture position. Only patients with an unambigiously inflammated or noninflam-
mated benign histologic result were included. Evaluation showed that a sensitivity 
of 90.6 percent and a specificity of 64.2 percent was reached. Finally, the prospec-
tive positive and negative predictive value for prostatitis was 50.0 percent and 
94.6 percent, respectively. This means that AUDEX predicts the diagnosis prostati-
tis in a large number of patients with no infection. In case of prostatitis however, 
this prediction is almost allways correct. 
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INTRODUCTION 
Prostatitis is a condition in adult men associated with a variety of complaints 
such as: pain in the lower abdomen, pain in the perineum, orchialgia, urethralgia, 
pain in the groin or loin, urethral discharge, pain at ejaculation, and/or micturition 
complaints [1]. Although the term prostatitis implies an infectious disease, in some 
cases an infectious origin of that condition is seriously doubted. Infectious causes 
have been the most widely studied, but a recent review showed that only a minori-
ty of patients were found to have a bacterial infection [2]. Thus the majority seems 
to suffer from a disease most probably related to the prostate without any signifi-
cant abnormalities. In two third of these patients, an infection is suspected because 
the prostatic fluid reveals an elevated leucocyte count. The search for a causative 
agent however, is unrewarding. In the remaining patients, no signs of infection are 
found and extraprostatic causes are suspected [3-5]. Therefore, besides the prosta-
tic localization test as developed by Stamey and Meares [6], other methods are 
needed to establish the diagnosis in these patients with prostatitis. 
Over the past several years, much interest and enthusiasm has been directed to-
wards defining both value and limitations of TransRectal Ultrasonography (TRUS) in 
evaluating patients with prostatic disease. By moving the transrectal probe along 
the .longitudinal axis, the entire prostate gland can be imaged. Sonographically, the 
normal prostate has a well-defined, highly echogenic capsule, which is continuous 
and symmetric. The internal sonographic structure of the prostate is composed of 
multiple, diffuse, homogeneous echoes that probably represent acoustic interfaces 
created by the numerous glands present [7,8]. In benign hyperplasia, the gland is 
diffusely enlarged, appears more round than the triangular normal prostate, and has 
a thickened capsule. The sonographic appearance of prostatic carcinoma is variable: 
small carcinomas mainly appear hypoechoic and enlarged lesions may appear hy-
poechoic, hyperechoic or isoechoic [9-11]. TRUS is also said to offer a substantial 
contribution to the diagnosis of prostatitis. Several authors have described charac-
teristic ultrasound features in patients with prostatitis, e.g. capsular thickening and 
prostatic calculi [12,13]. Also non-specific echogenic differences have been descri-
bed [14]. Because of these contradictions, we conducted a study in which the 
echographic images of the prostate in patients with prostatitis were compared with 
those of a control group without complaints related to the prostate. In that study 
we concluded that no specific characteristic ultrasound features could be found 
[15]. 
In conclusion, several ultrasound features are described correlated with the dia-
gnosis of prostate abnormalities. These abnormalities can be cathegorized accor-
ding to the anatomical presentation (e.g. capsular irregularity or elongation of the 
seminal vesicles) or the description of the echotexture and echogeneity. Although 
TRUS is the imaging technique of choice in the evaluation of prostate abnormalities, 
there are still many controversions. To overcome this problem, at our department a 
system is developed for the automated analysis and interpretation of TRUS images 
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(AUDEX = Automated Urologie Diagnostic EXpert system)[16]. This system is used 
to archive data, for automated volume measurements and for image analysis. One 
of the advantages of image analysis is that information in the image, hidden for the 
human eye, can be detected [17]. Because of the good results reached by AUDEX 
in the differentiation between malignant and benign tissue (sensitivity 89.3%, spe-
cificity 78.1%), this ¡mage analysis technique was also used to see if it is possible 
to differentiate between non-inflamated and inflamated benign prostate tissue. 
MATERIAL AND METHODS 
With a Kretz Combison 330 ultrasound scanner with a transrectal probe (Multipla-
ne 3-D rectal transducer VRW 77AK), longitudinal and transverse prostate images 
are recorded. All investigations were performed by 1 urologist, experienced in per-
forming TRUS. Based on an ordinary personal computer (486 DX2, 66 MHz) with 
additional framegrabber (PcVision Plus framegrabber), connected to the video out-
put of the ultrasound machine, a system is developed for the classification of pros-
tate tissue: Automated Urologie Diagnostic EXpert (AUDEX) (figure 1). 
figure 1 : sceme of the setup of the AUDEX system 
ч Ultrasound scanner 
Personal 
computer 
.щшшш Probe 
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Before the system can classify images, it should learn the difference between 
images from inflammated and non-inflammated tissue. For this reason, images from 
tissue with known histology had to be recorded. Two consecutive ¡mages were 
stored from every location where a prostate biopsy was taken. The first one was 
recorded before the biopsy was taken and used for further analysis. The second 
one was recorded just after the biopsy needle entered the gland (figure 2). In this 
ultrasonographic image, the puncture needle is still visible and determines the area 
which has to be analyzed in the first image (figure 2). During this analysis, several 
image processing parameters (uniformity, contrast, inverse different moment, entro-
py and correlation) are calculated that are used to determine the probability for 
malignancy. 
Figure 2: Presentation of image (A) before and (B) after puncture biopsy of the 
prostate. 
90 Chapter 8 
The correlation between the values of all biopsies and the histology of the corres­
ponding tissue (figure 3) were determined with the use of binary decision trees 
( = hierachical representation of the decisions). The texture analysis parameters 
used here, have been described extensively in another paper and will be presented 
seperately [18]. Once a decent decision tree has been constructed, the system can 
be used in a predictive way: ultrasound images of the prostate are labeled "inflam-
mated" or "non-inflamated". The labeled images are presented in colours. Every 
color code represents the estimated probability of the presence of inflammated 
tissue (red = 100% chance, blue = 0% chance) (figure 4). The only aim of the pre­
sent study was to investigate whether this AUDEX system is able to distinguish 
images of inflammated from images of non-inflammated prostate tissue. To obtain 
optimal results only patients with a clear inflammation or noninflamated histology in 
the biopsies were included in this study. Patients with carcinoma were excluded as 
well as atypia. 
figure 3: presentation of the correlation made between the results of the image 
analysis and histology. 
Ultrasonography 
Image acquisition 
ι 
Image analysis 
Tissue biopsies 
ι 
Tissue histology 
Correlation 
ι 
Prediction 
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Figure 4: Audex analysis in a patient with (A) inflammated and (B) noninflam-
mated tissue. 
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RESULTS 
In 278 patients, one or more TRUS guided prostate biopsies were taken to exclu-
de prostate cancer The histological examination revealed, besides benign prostatic 
hyperplasia ( = non-mflammated), prostatitis ( = inflammated), carcinoma and atypia. 
From these data, those patients were selected with an unambigiously benign nonm-
flammated (n = 81) or benign inflammated (n = 32) histology result. Two-third of 
samples were used for the learning phase while all samples were used for evaluati-
on. We followed this approach because a reasonable number of samples was requi-
red to construct a classification tree This classification tree was then used for 
evaluation of all samples. Reasons for biopsy in these patients were: abnormal DRE 
(n = 44), elevated PSA (>10 ng/mL) (n = 70), and/or suspicious TRUS (n = 29). In 
patients with inflammation, the DRE was abnormal in 56 percent and TRUS was 
suspect for malignancy in 59 percent. In patients with benign non-mflamated tissue 
these values were 37 and 41 percent, respectively. 
In 13 patients of the inflammated group (n = 32), TRus showed no abnormalities 
while AUDEX indicated 12 patients (92%) to have an inflammation. In the remai-
ning 19 patients with inflammation, in whom TRUS was suspect for carcinoma, 
AUDEX predicted prostatitis in 17 patients (89%). In the non-inflammated group 
(n = 81), in 48 patients (59%) the TRUS showed a benign image. In 23 cases 
(48%) however AUDEX predicted prostatitis. If the TRUS was suspect for carcino-
ma, AUDEX only predicted inflammation in 6 patients (18%). When we look at the 
results of DRE, in the patients with histologically proven prostatitis, in 14 cases 
DRE was suspect for carcinoma In 12 patients (84%) of this group, AUDEX predic-
ted inflammation In the patients with no signs of inflammation, DRE was suspect 
in 30 patients while AUDEX predicted inflammation in 10 of these patients (33%). 
It is interesting to notice that in the majority of these patients, TRUS showed no 
abnormalities. Finally, in 3 patients AUDEX missed the diagnosis inflammation while 
29 patients without inflammation were said to have an inflammation according to 
AUDEX (table 1). When we look at the results the values are: sensitivity 90.6 per-
cent, specificity 64.2 percent, predictive positive value 50.0 percent and predictive 
negative value 94.6 percent (table 2) 
DISCUSSION 
Although prostatitis appears to be one of the most common pathologic conditions 
encountered in urology, a number of questions have as yet to be answered concer-
ning etiology, diagnosis, and treatment. The classification of patients with prostati-
tis is based on a judicious bacteriologie assessment of the lower urinary tract accor-
ding to the technique of Meares and Stamey [6]. However, the major problem in 
diagnosis of these patients remains the evaluation of this test, it has a low sensiti-
vity; its interpretation criteria are, as yet, not unambigiously defined;! 19,20] it 
taxes the patients, is time-consuming, and is relatively expensive. Thus, other me-
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Table 1: Crosstable of TRUS results, DRE findings and the prediction of the 
AUDEX system in the inflammated group and noninflammated group 
(A+ = AUDEX predicts inflammation. A- = AUDEX predicts no inflam-
mation). 
DRE 
TO >T0 
A + A + A- total 
infiammateci 
noninflammated 
TRUS 
UTO 
>UTO 
total 
UTO 
>UTO 
total 
10 
7 
17 
15 
4 
19 
0 
1 
1 
18 
14 
32 
2 
10 
12 
8 
2 
10 
1 
1 
2 
7 
13 
20 
13 
19 
32 
48 
33 
81 
Table 2: Crosstabel of histology and prediction by AUDEX in 113 patients. 
Histology 
non-inflammated 
AUDEX prediction 
non-inflammated inflammated 
52 29 
Total 
81 
inflammated 29 32 
Total 55 58 113 
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thods are needed to delineate this group of patients with so-called prostatitis. Alt-
hough, still to be established as a decisive method in the diagnosis of prostatitis, 
prostatic ultrasound can offer a substantial contribution. 
The quality of TRUS has been improved markedly in the past few years, and an 
experienced urologist can detect suspicious lesions in the prostate with reasonable 
accuracy [8,21]. However, some disadvantages are still attached to the use of 
TRUS. First, not every abnormality appears the same in ultrasonographic imaging; 
some appear hypoechoic, others are an or isoechoic [9-11). Furthermore, not all 
lesions are abnormalities; many of the lesions are artifacts, benign prostatic disea-
ses, or even normal biological structures [21]. Another disadvantage of TRUS is its 
subjectivity, which is related to inherent limitations of the ultrasonic imaging pro-
cess. Interpretation of ultrasonographic prostate images highly depends on the 
experience and expertise of the urologist and his ability to distinguish between 
artifacts, benign structures, and cancer [21]. Besides, the urologist will use additio-
nal knowledge, such as DRE and PSA, in his interpretation of TRUS images, and 
conclusions drawn are not merely based on the information in the images [21,22]. 
Also the ultrasound features of inflammatory prostatic disease have caused con-
fusion from the earliest days of prostatic ultrasonography. Despite technologic 
improvements, certain sonographic features of inflammatory prostatic disease appe-
ar similar to prostate cancer features [23,24]. Several authors attempted to deter-
mine whether it is possible to demonstrate characteristic ultrasonographic pictures 
in patients with prostatitis [12,14,25]. These results seemed promising. The inves-
tigators noted several features of significance, namely a hypoechoic "halo" in the 
periurethral region, an ill-defined capsula, capsular thickening, a heterogeneous 
echo pattern, prostatic calculi and, enlargement and thickening of the septae of the 
seminal vesicles However, in contrast to these results, in another study we were 
unable to confirm these findings [15]. Therefore in general we may conclude that, 
in spite of improvements of the ultrasound equipment regarding resolution and grey 
scale, interpretation of ultrasound images is still difficult and subjective. 
The results reached with AUDEX in detection of prostate carcinoma shed a new 
light on the image interpretation of ultrasound images [16]. This technique enables 
the user, instead of a subjective interpretation of the ultrasound image by eye-ball, 
to analyse and interpret such an image with sophisticated image processing tools. 
The sensitivity and specificity reached in this research with image analysis are 
comparable to, or better than the results presented for regular examination [16]. A 
prospective predictive value for cancer detection of 85.7 percent could be reached. 
Because the results of automated analysis of ultrasonic prostate images were 
very promising and the diagnostic problem in prostatitis patients, the study reported 
in this paper was initiated; the AUDEX system was used to differentiate between 
inflammated and noninflammated benign prostate tissue. The data of the patients 
were collected from a data bank of patients who underwent biopsies because of an 
abnormal DRE, TRUS or elevated PSA. In none of these patients the prostatic locali-
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zation studies, as described by Stamey and Meares, have been performed In an 
earlier study. Doble et al. showed that in patients with chronic abacterial prostatitis, 
the histology of prostate biopsies revealed a chronic inflammatory infiltrate in 88% 
of these patients [26]. This study suggests a good correlation between the results 
of the localization test and the histology of the prostate. Because in the present 
study we were able to predict inflammation with AUDEX, it is worth while to ex­
tend this study to research in patients with prostatitis complaints in general and 
compare the result of the AUDEX system with the results of the localization test. 
The ability to place a biopsy needle accurately under ultrasound control has ena­
bled histologic assessment of the parenchymal features. In patients with prostate 
carcinoma AUDEX seems to be able to predict carcinoma more accurately than any 
other diagnostic tool [27]. In patients with prostatitis, the predictive results are 
reasonable good although less compared to carcinoma patients. Furthermore in 
many patients the diagnosis inflammation was made while the tissue was non-m-
flammated. This may be explained by the fact that changes in carcinoma cells are 
more deviant from normal than the changes seen in inflammated cells. In only 3 
patients, AUDEX failed to diagnose prostatitis and thus AUDEX seems to be capa­
ble to detect inflammation accurately This means that with the use of this system 
solely for diagnosis and treatment with antibiotics of patients with prostatitis syn­
dromes this would result in: a "missed" treatment of a very small number of pa­
tients while quite a number of patients would be overtreated. One must realize 
however, that currently only approximately 10 percent of the localization tests in 
patients with prostatitis syndromes show a proven infection. These patients are 
correctly treated with antibiotics But in the majority of patients with complaints of 
prostatitis syndromes also a course of antibiotics is prescribed [2]. AUDEX may 
"prevent" overtreatment with antibiotics and this means that AUDEX indeed can 
contribute to the diagnosis of prostatitis and the decision to treat with antibiotics or 
not. Furthermore AUDEX has a higher sensitivity, it taxes the patients less, is less 
time consuming and less expensive than the localization test. It seems obvious that 
in case of complaints of prostatitis syndromes, it would be preferable to use ima­
ging techniques instead of the localization test to make the diagnosis prostatitis. 
Finally, this study shows that, in patients with inflammation, the DRE was abnor­
mal ОТО) in 56 percent and TRUS was suspect for malignancy in 59 percent 
Stillwell et al. also reported that in 59% of the patients with granulomatous prosta­
titis, the prostates presented suspicious clinically for malignancy [28]. Because the 
prostate of patients with prostatitis can mimic carcinoma, it would be ideal if AU­
DEX is able to differentiate between carcinoma and prostatitis. This issue is dealt 
with in another study in progress and the results will be presented in a seperate 
paper. From the present study we may conclude that in principle AUDEX is capable 
of differentiation between inflammated and noninflammated tissue. 
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CONCLUSION 
The potential value of prostatic imaging in the diagnosis of inflammatory disorders 
of the prostate is largely unexplored. In several studies, specific ultrasonographic 
characteristics in patients with prostatitis have been described. Also nonspecific 
echogenic qualities in prostatitis have been pointed out. New areas of technical 
research such as computer analysis should further increase the scope of applicati-
ons of transrectal sonography. The first results of such an application, the AUDEX 
system, are very promising. The AUDEX system can play an important role in every 
day clinical practice. It can support the urologist in his interpretation of ultrasono-
graphic prostate images and the diagnosis and treatment of prostatic diseases. 
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RESEARCH IN "PROSTATITIS SYNDROMES": THE USE OF ALFUZOSIN (A NEW 
orl-RECEPTOR BLOCKING AGENT) IN PATIENTS MAINLY PRESENTING WITH 
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ABSTRACT. 
A double-blind, placebo-controlled study in 20 patients with "prostatitis syndro­
mes" and confirmed urodynamic abnormalities using the σ1-receptor blocking com­
pound alfuzosin is reported. Flow rate recordings are probably the most reliable and 
useful objective variables in this type of investigation. There is a significant benefi­
cial effect in the group using an active compound concerning maximal flow 
(p = 0.01), flow time (p = 0.03) and time to maximal flow (p = 0.01). However, com­
pared with the group using a placebo, only the change in the maximal flowrate 
appeared to be significantly different. Subjective effects were more pronounced in 
the alfuzosin group, but the spurious nature of subjective observations is stressed. 
Alfuzosin seems to be effective compared to placebo, based on objective parame­
ters, in the treatment of these patients with micturition complaints of an irritative 
nature and urodynamic abnormalities while only minor side effects were noticed. 
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INTRODUCTION. 
Typical complaints of patients with "prostatitis syndromes" are: pain in the 
perineum, the suprapubic area, the lower back, the testicles, the groin, the flank, or 
in the urethra on ejaculation. Urinary symptoms may include urgency, frequency, 
dysuria and urethral discomfort. 
Diagnosis in these patients is difficult and treatment is often unsuccessful. 
Besides this, there is a lack of uniform terminology for various forms of "prosta­
titis". Drach et al. [1] divided "prostatitis" into four categories, that they believe are 
useful in research and clinical practice. These categories are: acute bacterial 
prostatitis, chronic bacterial prostatitis, non-bacterial prostatitis and prostatodynia, 
depending mainly upon an analysis of prostate fluid. 
There is no objective evidence of prostatic inflammation among patients with 
prostatodynia and non-bacterial prostatitis. On examination, the prostate is found to 
be normal in size, shape, and consistence and there is minimal tenderness. Re­
search concerning the origin of these disorders has been directed towards the 
illumination of extra-prostatic etiologies. Uroflowmetry abnormalities are reported in 
30% of the cases [21. Urodynamic testing in these patients has frequently shown 
functional disorders of the lower urinary tract: disorders of the bladder outlet [31, 
detrusor hyperreflexia, and detrusor areflexia with nonrelaxing pelvic floor striated 
musculature [4]. Pelvic floor tension myalgia due to habitual contraction and spasm 
has also been suggested as a possible cause [5,6]. 
Untili now, the actual cause of most cases of prostatitis remains unclear, with 
many uncertainties concerning methods of diagnosis and treatment. We present the 
results of a pilot study performed for 20 patients using alfuzosin, a new σ1 -receptor 
blocking compound, and discuss future treatment modalities. We also review the 
knowledge concerning prostatitis in the presence of confirmed urodynamic abnor­
malities. 
MATERIAL AND METHODS. 
The study aims to determine the efficacy of alfuzosin in remission of sympto­
matology and improvement of uroflowmetry. 
Twenty patients met the inclusion criteria and gave informed consent for this 
study, which was approved by our ethical review board. Patients were included in 
this study when the diagnosis prostatodynia or non-bacterial prostatitis was made 
and they presented themselves with a dysuric uroflow (voided volume > 1 5 0 mL, 
maximal uroflow < 2 0 mL/s, residual urine < 1 0 0 mL). This diagnosis prostatodynia 
and non-bacterial prostatitis was made by the combination of the history, as 
presented in prostatitis, and a negative semen culture. 
A detailed analysis of the character and duration of the symptomatology, the 
results of prior investigations and the response to prior treatments were critical 
components of the history. The complaints at initiation of the study and during 
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follow up were monitored using a symptom score (figure 1). 
A complete physical examination including neurological and rectal examination 
was performed. Also laboratory examinations were done, including a full blood 
count, serum creatinine, serum acid phosphatase, serum alkaline phosphatase, 
prostate specific antigen, ESR, ASAT, ALAT, gamma-GT, LDH and glucose 
determination, together with a routine urine analysis including microscopy. A 
sonography of the prostate and the kidneys was performed as well as a plain X-ray 
of the abdomen. Finally endoscopy of the bladder and urethra and an urodynamic 
investigation were performed. Urodynamic assessment in all cases consisted of 
medium fill cystometry (50 mL/min) using URO-GYN UDS 1002 equipment with a 
Gaeltec catheter. This catheter was inserted transurethral^ and the bladder was 
filled in supine position with an isotonic salt solution at room temperature. Simul­
taneously, a perineal electromyography was recorded using ЗМ-monitoring electro­
des (dots). Finally, all measurements were registered with a 6 channel chart 
recorder; pelvic floor EMG, bladder pressure, uroflowmetry, rectal pressure and the 
difference between bladder pressure and rectal pressure. 
Figure 1 Symptom score for evaluation subjective response 
0 1 2 3 4 5 6 7 8 9 1 0 
pollakisuria: 
dysuria: 
stranguria: 
dribbling: 
suprapubic pain: 
groin pain: 
peni-scrotal pain: 
perineal pain: 
myalgia: 
back pain: 
score: ( 0 - 1 0 0 ) 
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Administration of alfuzosin medication and placebo medication was randomized 
and double-blind. An equal number of patients received either alfuzosin or placebo. 
All patients were informed about the placebo controlled set up. Each patient 
received 1 tablet 3 times daily for 6 weeks, either 2.5 mg alfuzosin or placebo, 
according to a random code. 
Each patient was seen 3 weeks and 6 weeks after the beginning of the experi­
ment. At the beginning and at 6 weeks an urodynamic investigation was performed 
(Figure 2 and 3). At 3 weeks only the uroflowmetry was done. In addition, at the 
time of the inclusion visit and at 6 weeks, the patient were given a chart and 
requested to record his daily evaluation of the severity of the symptoms A routine 
medical examination was done at inclusion. Any possible side effects of the treat­
ment, together with their time of onset, severity and duration, were recorded. 
The statistical tests used were the signed-rank test of Wilcoxon for comparisons 
within groups and the two-sample test of Wilcoxon for comparisons between 
groups. The level of significance was 5%. For within-group analyses the tests were 
two-sided, while in comparing the effects of placebo and alfuzosin, one-sided 
alternatives were used to assess whether or not alfuzosin is better than placebo 
Figure 2 Uroflowmetry evaluation, in the same patient as presented in figure 
3, at initiation of the study (a) and after completion of the study (b) 
without the presence of transurethral catheters 
50 ml/s Flow Rate 
50 mUs Flow Rate 
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Figure 3 Urodynamic investigation in a patient an using alfuzosine medica-
tion at initiation of the study (a) and after completion of the study 
(b); 1 uroflowmetry, 2 external urethral sphincter, 3 difference 
between intravesical pressure and rectal pressure ( = detrusor 
pressure), 4 rectal pressure, 5 intravesical pressure, 6 pelvic floor 
EMG. 
RESULTS. 
The age of the patients ranged from 31 to 54 years (mean 41,0) in the placebo 
group and from 23 to 50 (mean 37,8) in the alfuzosin group. History revealed no 
abnormalities with regard to diet, neurological complaints, cardial problems, sexual 
infectious diseases or psychosexual problems. 
Presenting symptoms: The duration of symptoms was at least 1 year and in 4 
patients 10 years. The most frequent symptoms were voiding complaints with or 
without suprapubic, penile or scrotal discomfort (table 1). A sense of urgency 
immediately after voiding was common and also hesitancy in combination with 
weak stream often was described to be variable in severity. 
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Table 1 Presentation of main complaint in the total group and complaints in 
decreasing sequence with the results of the mean symptom score 
(range 0-10) for each study group at initiation of the study (week 0) 
and after completion of the study (week 6). 
main complaint placebo alfuzosin 
(no patients) week 0 week 6 week 0 week 6 
dribbling 
frequency 
peni-scrotal pain 
dysuria 
suprapubic pain 
backpain 
stranguria 
perineal pain 
myalgia 
groin pain 
5 
5 
4 
2 
2 
1 
0 
0 
0 
1 
4.3 . 
2.9 
1.7 
3.5 
2.1 
1.7 
0.8 
0.5 
0.2 
0.4 
3.3 
2.4 
1.5 
3.1 
1.5 
1.5 
0.7 
0.5 
0.2 
0.1 
2.8 
2.8 
2.9 
2.2 
1.7 
0.4 
0.3 
1.0 
0.4 
0.0 
1.7 
1.3 
1.8 
1.6 
0.6 
0.4 
0.3 
0.4 
0.2 
0.0 
Total score 20 19.1 16.2 14.5 8.3* 
* p = 0.01 
Symptom score: Evaluation of the change in symptom score in both groups was 
significant in the alfuzosin group (p = 0,01) but not in the placebo group (p = 0,06). 
There was a good correlation between symptom improvement and flow improve­
ment. 
Urologie examination: Complete physical examination, including rectal examina­
tion was performed and showed, except for a tender prostate in two patients, no 
abnormalities. All patients had a neurologic examination that revealed no abnor­
malities. Transrectal sonography of the prostate and sonography of the kidneys 
showed no abnormalities. In one patient, the X-ray of the abdomen showed a 
kidney stone that was successfully treated by ESWL but the patient kept complai­
ning of pain after the treatment. 
Endoscopy of the bladder and urethra was performed on 15 patients. In all cases, 
endoscopy revealed tightening of the bladder neck sometimes with an accompany­
ing posterior urethral erythema. 
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Urodynamics: Results of an urodynamic assessment are presented in table 2. 
Detrusor pressure showed no significant difference between the two groups of 
patients, and perineal EMG showed no abnormalities. Uroflowmetry was performed 
during the use of the medication, three days following the urodynamic investigati­
on. In this way, the results were not disturbed by the transurethral catheter. 
Analysis of the results, during the use of alfuzosin, showed significant changes in 
maximal flow rate (p = 0.01), flowtime (p = 0.03) and time to maximal flowrate 
(p = 0.01). However, compared with placebo, only the change in maximal flow rate 
appeared to be significantly different (p = 0.03). If improvement was judged on the 
change in urodynamic parameters alone, eventually eight patients in the alfuzosin 
group compaired with two patients in the placebo group, improved objectively 
(p = 0.01). 
Table 2 Presentation of parameters (mean value) in patients using placebo 
(n=10) and patients using alfuzosin (n=10) at initiation of the 
study and after completion of the study. 
Variable 
Placebo 
week 0 week 6 
age (years) 41 
symptomscore (0-100) 
systolic pressure (mm Hg) 
diastolic pressure (mm Hg] 
detr. contraction (cm H20) 
maximum flow (mL/s) 
flow time (s) 
time to max flow(s) 
flow volume (mL) 
residual urine (mL) 
19.1 
131 
76 
13.9@ 
60.2 
11.7 
451 
54 
16.2 (*) 
131 
78 
66 
15.6 
43.5 
10.0 
383 
37 
week 0 
37.8 
14.5 
131 
81 
15.4 
51.9 
14.5 
478 
40.5 
Alfuzosin 
week 6 
8.3 * 
128 
77 
58 
20.3 * 
34.6 * 
8.5 * 
376 
15 
* ρ < 0.05 and (*) 0.05 < ρ < 0.10 for comparisons within groups 
@ ρ < 0.05 for comparisons between groups 
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Post-Voiding Residual Urine: Post-voiding residual urine was measured by 
catheterization at the beginning of the trial. There was no significant difference 
between both study groups (table 2). 
Laboratory results: Laboratory examination of blood and urine showed no 
abnormalities in either patient group. Semen cultures as well as the leucocyte count 
in semen, showed no signs of infections. 
Side effects: Blood pressure was measured in the supine position. In the group 
using alfuzosin, there was a small decrease in systolic blood pressure in four 
patients and in one patient symptoms were reported which could be attributed to 
postural hypotension. These complaints lasted only for two days Complaints of a 
slight decrease of libido were reported in two patients. 
DISCUSSION. 
Little is known about the etiology, diagnosis and treatment of "prostatitis syndro­
mes". An important component in the management of the patient with this problem 
involves the elimination of extraprostatic causes, explaining the symptomatology. 
Interstitial cystitis and carcinoma in situ of the urinary bladder should be ruled out 
by cytologic examination of the urine and eventually cystoscopy and bladder biopsy 
[7]. Care should also be taken to exclude other problems, such as osteitis pubis or 
urolithiasis, which may masquerade as prostatitis [81. 
Urodynamics: Urodynamic investigations in patients with "prostatitis syndromes" 
are warranted if voiding disturbances constitute a major component of the sympto­
matology [3-5,9-14). A urodynamic study by Siroky et al. [4] in 47 men who com­
plained of recurrent voiding symptoms and a реп-genital pain syndrome, showed 
evident urodynamic abnormalities in 86% of the patients, e.g bladder areflexia 
with a non-relaxing perineal floor or hyperreflexia. 
The most striking finding in the study by Barbahas et al. [9] performed on 20 
patients with prostatodynia, was a significant increase in the maximum urethral 
closure pressure with an incomplete tunneling of the bladder neck during voiding 
These findings suggest a primary abnormality involving the pelvic sympathie 
nervous system. Also Awad and Downie [13) think of involvement of the 
sympathie nervous system in patients with these complaints. They term this 
disorder a sympathetic dyssynergia, primarily because this condition responded 
favorably to therapy using alpha-blockers. 
Studies by Segura et al. [5] and Sinaki et al. [11] indicated that prostatodynia 
may be caused by the detrusor striated sphincter dyssynergia or a tension myalgia 
of the pelvic floor. We could not confirm the detrusor striated sphincter dyssynergia 
in this study. Figure 2 shows conclusively that during micturition there is a good 
relaxation of the external urethral sphincter, a good detrusor contraction and no 
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signs of detrusor sphincter dysynergia. These features are noticed at initiation and 
at the end of the six weeks study period. It seems obvious that the effect of alfu-
zosin (improvement of uroflow, related to smooth muscle relaxation of the bladder 
neck) seems to confirm the theory of bladder neck dysfunction in these patients. 
Bladder neck dysfunction was also evaluated in sixteen male patients by Webster 
et al. [3]. In six patients the diagnosis had been chronic prostatitis. It is suggested 
that the bladder neck obstruction could be due to fibrotic bladder neck narrowing as 
a result of a chronic inflammation. On the other hand one can imagine that bladder 
neck dysfunction is the cause of irritation of the prostate leading to "prostatitis 
syndromes". The onset of detrusor instability based on the bladder neck obstruction 
will result in frequency, nycturia and urgency, which invariably will raise the 
suspicion of prostatitis in a young man. Therefore, obstructive urinary symptoms in 
the younger male patient should always raise the question of the bladder neck 
dysfunction and on adequate evaluation is essential. However, it is remarkable that, 
in spite of the dysuric flow and the hyperactive bladder neck, no significant signs of 
hypercontractility of the striated detrusor could be noticed. 
Another cause of micturition complaints may be the presence of poor detrusor 
contractions. George and Slade [10] reported on a series of patients in whom the 
symptoms of frequency, hesitancy and poor stream were associated with a 
particular urodynamic pattern - poor flowrate, and typically intermittent in nature 
due to poor detrusor contractions - in the absence of any convincing abnormality. 
Patients complained of a persistent sensory urethral desire to void which did not 
require voluntary sphincter activity as a countermeasure. Other common symptoms 
were suprapubic bladder pain, which worsened if micturition was delayed, loin-to-
groin ache and dysuric voiding pains in the absence of infection. Also, in our series, 
most patients show similar micturition complaints. Unlike the results of George and 
Slade [10] there where good detrusor contractions during micturition (figure 2). 
Therapy: The human bladder body contains both a- and B-adrenergic receptors, 
with the ß variety being the more common. The bladder base, the proximal urethra 
and the prostate smooth muscle contain predominantly alpha,-receptors, though 
beta receptors are also present. These alpha,-receptors mediate smooth muscle 
contraction. Thus alpha,-receptor blockage will cause a smooth muscle relaxation in 
the bladder base, the proximal urethra and the prostate [15,16]. Furthermore it is 
hypothesized that alpha,-receptor density increases in hypertrophic smooth muscle 
[17]. 
Krane & Olsson [18] described the concept of a physiological internal sphincter, 
controlled partly by a tonic stimulation of contractile σ,-receptors in the smooth 
musculature of the bladder neck and proximal urethra by the sympathetic nervous 
system. They presented evidence that σ-adrenergic blockade would be useful in 
treating a patient with an adequate bladder contraction but without an anatomical 
obstruction or detrusor striated sphincter dyssynergia. The present study seems to 
confirm these conclusions, as there is a good objective response. 
In several studies, the results of the medical treatment in patients with bladder 
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complaints of an irritative nature and urodynamic abnormalities have been descri­
bed. Awad and Downie [131 were among the first who presented the results of 
treatment using σ-blockers in patients with urodynamic abnormalities. They term 
this disorder sympathetic dyssynergia primarily because this condition responded 
favorably to therapy using σ-blockers [13]. Other authors confirmed this favorable 
effect, caused by an alpha-receptor blockade, in patients with bladder neck 
dysfunction [19-21]. Also Osborn et al. [12] stated that patients with prostatodynia 
and urodynamic abnormalities should be treated with σ-blockers. A 50 % symp­
tomatic response was found in patients treated with σ-blockers [12]. We also 
noticed a significant improvement of subjective complaints in patients using the 
active compound alfuzosin. It is not easy to judge the effect of a medical treatment 
of "prostatitis syndromes". The subjective parameters are not precise and are very 
changeable - improvement can be seen when giving a placebo. In using the here 
presented symptom score it is possible to study these subjective parameters more 
acurately. With the experience from other studies in patients with "prostatitis 
syndromes", we would advise to use this symptom score to judge the subjective 
response. 
Although only a few studies in this field have been performed, results of medical 
treatment seem very promising. The here presented study clearly showed that only 
20 patients were required to prove a statistical significant objective and subjective 
response. Thus alfuzosin is an active compound in the treatment of patients with 
"prostatitis syndromes" and confirmed urodynamic abnormalities. 
In summary, the actual cause of most cases of "prostatitis syndromes" remains 
unclear; likewise, many uncertainties exist regarding the pathogenesis, methods of 
diagnosis and treatment. Research directed towards extra-prostatic etiologies, using 
urodynamics, has shown functional disorders of the lower urinary tract. The results 
of the treatment of these patiens with σ-receptor blocking medication seems very 
promising. 
Alfuzosin alleviates the irritative symptoms (significant subjective response) of 
patients with "prostatitis syndromes", mainly presenting with irritative micturition 
complaints, and urodynamic abnormalities and improves the uroflow (significant 
objective response), without causing unwanted major urological or generalized side 
effects. Most important, alfuzosin improves the flow significantly more than place­
bo. 
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SUMMARY AND CONCLUSIONS 
Urologists are frequently consulted by patients presenting vague complaints: pain 
in the perineum, in the suprapubic area, in the lower back, in the testicles, in the 
groin, in the flank, urgency, frequency, dysuria, urethral discomfort and hemato-
spermia From their history the diagnosis prostatitis syndromes is made and it des-
cibed more or less a disorder that might originate from a disorder of the prostate 
gland. In Chapter 1 an overview is given of the tedious improvement made during 
the last century concerning the diagnosis and treatment of patients with prostatitis 
syndromes. We agree with Stamey, who developed the golden standard for diagno­
sis of the various form of prostatitis, that little more is known than at the beginning 
of this century. Especially diagnosis and treatment of patients with non-bacterial 
prostatitis, representing the majority of patients, is extremely difficult. The factors 
and organisms contributing to nonbacterial prostatitis are confusing, contradictory 
and poorly defined. This finally resulted in all kinds of theories and a whole range of 
therapies. It seems that most of these therapies start with antibiotics and end with 
a frank discussion of the nature of the condition: nothing can be done. 
In Chapter 3 we summarize the results achieved in diagnosis and treatment of 
more than 400 patients with prostatitis syndromes, treated at our outpatient de­
partment. The patients were in their mid forties and most of them were complaining 
for less that six months. Radiodiagnostic workup was unrewarding and therefore 
we concluded that these imaging techniques are of limited use in the screening of 
patients with prostatitis syndromes. Of course urine analysis should allways be 
performed and urine culture and cytology as well. Uroflowmetry abnormalities were 
seen frequently which may be caused by extraprostatic causes. Because these 
patients seem to respond favorably at σ,-blocking agents, uroflowmetry should 
allways be performed. The results of antibiotics treatment were disappointing. 
Similar results were reached if no antibiotic treatment was initiated (cure, improve­
ment and stable disease in one third each). More than one course of antibiotics 
should not be administerd. 
In Chapter 4 we present the results of a questionnaire among Dutch urologists 
and general practitioners concerning diagnosis and results of treatment of patients 
with prostatitis syndromes. From this study we may conclude that patients seen by 
the urologists seem te be younger and mainly complaining about pain in perineum, 
penis and scrotum. The further workup of the urologists consists of the four glass 
test and also uroflowmetry is performed frequently. General practitioners on the 
other hand see most frequently older patients with micturition complaints. Therefo­
re we question whether many patients seen by the general practitioners are not just 
suffering from prostatism due to benign prostatic hyperplasia. There is also a remar­
kable difference between the two groups concering the cause of the complaints. 
General practitioners consider a bacterial infection as the causative agent while 
urologists mention non-bacterial infections most frequently. There is also an evident 
difference in the opinion regarding the psychosomatic contribution to this "disea-
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se". Maybe there is a relation between the outcome of therapy and psychosomatic 
influences. General practitions mention acceptable cure rates and in their opinion 
psychosomatic factors contribute only minimally Urologists gain bad results with 
their treatment and it seems logical that there is a strong feeling towards psychoso-
matic etiologies. Although in many cases infections cannot be traced, the first-
choice treatment by both groups consists of antibiotics 
Because of the widely held assumption of psychosomatic factors in patients with 
prostatitis syndromes, we conducted a study to identify the personality variables 
involved in patients with prostatitis syndromes. In Chapter 5 a group of 50 chronic 
prostatitis patients was compared to a group of 50 patients seen for vasectomy. 
We found statistically significant differences between patients with prostatitis and 
the control group. These differences however, were not of a great magnitude and 
minor compared to the scores of psychiatric patients Further analysis pointed to 
somatisation and depression as the most frequent characteristics in prostatitis 
patients. From this study we may conclude that is seems unfounded to label these 
patients with prostatitis syndromes "neurotic" or "psychopathologie". Moreover it 
is impossible to conclude that there are personality variables that are specific for 
these patients. In case of an elevated score on depression it is suggested that some 
of these patients, and predominately those presenting pain complaints, may impro-
ve on a trial of low dose antidepressants. 
Because diagnosis in patients with prostatitis syndromes is difficult, one should 
at least be sure that serious deseases, resembling prostatitis, are ruled out. In 
Chapter 6 we present a retrospective study in patients, in whom the initial diagno-
sis "prostatitis" was made. In 6 3 percent of the urine samples, severe atypia was 
found. Further evaluation showed that in allmost half of these cases a bladder ma-
lignancy was found. The main complaints appeared to be pain and irritative bladder 
symptoms for the patients with malignancy while urine analysis always revealed 
erythrocytuna. Therefore we want to recommend urine cytology screening on all 
patients presenting prostatitis syndromes According to our questionnaire however, 
only 35% of the urologists perform cytologic examinations of urine samples in 
these patients 
Ultrasonography of the prostate is easy to perform, it is not uncomfortable for 
the patient, is relatively cheap and is the best choice for imaging of the prostate. 
The quality of transrectal ultrasound has been improved markedly in the past few 
years, and an experienced urologist can detect abnormalities in the prostate with 
reasonable accuracy. In patients with prostatitis syndromes however, various ultra-
sonographic patterns have been described. In Chapter 7 we describe our experience 
of ultrasonographic findings in patients with non-bacterial prostatitis From this 
study we concluded that in contrast with earlier findings, constant dilatation of the 
periprostatic venous plexus were more pronounced in the control group of healthy 
subjects as well as elongation of the seminal vesicles Prostatic calcifications were 
frequently encountered in both groups. We simply were unable to differentiate 
between disease and non-disease. Meanwhile at our department we were working 
on a system for automated analysis of ultrasound images. In Chapter 8 we present 
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the results of this system used in patients with histologically proven prostatitis. 
Earlier studies revealed a high correlation between histologically proven prostatitis 
and the outcome of the localization studies. Therefore we assumed that if we were 
able to detect prostatitis merely by image analysis of transrectal ultrasound investi­
gations, this would be a big contribution to the diagnosis of these patients. Evalua­
tion showed that a good sensitivity could be reached (90.6%) but that the specifici­
ty was lower (64.2%). The positive predictive value for prostatitis was 50% while 
the negative predictive value was 94.6%. This means that by this system quite a 
number of patients is falsely diagnosed as having "prostatitis". In patients with pro­
ven prostatitis however, this prediction is almost allways right. We concluded that 
this first results of this analysis are very encouraging. Improvement of the system 
can result in a diagnostic tool that can support the urologist in diagnosis and treat­
ment of patient with prostatitis. 
Finally in Chapter 9 we discuss our results reached in patients with prostatitis 
syndromes, mainly presenting micturition complaints and confirmed urodynamic 
abnormalities when using a σ,-receptor blocking drug. Because many patients suffe­
ring from prostatitis syndromes also present themselves with a poor flow, further 
evaluation frequently shows outflow problems. The aforementioned medication 
causes relaxation of the smooth muscles at the level of the bladder neck and the 
urethra prostatica. In this study both a significant subjective and objective response 
was observed. These results of the treatment of these patients with σ,-receptor 
blocking medication are very promising. 
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SAMENVATTING EN CONCLUSIES 
Urologen worden frequent geconsulteerd door mannen met een vaag klachtenpa-
troon: perineale pijn, suprapubische pijn, rugpijn, pijn in testikels, liezen, flank, 
urgency, frequency, dysurie, urethrale klachten en haematospermie. Op grond van 
de anamnese wordt de diagnose prostatitis syndroom gesteld hetgeen min of meer 
een aandoening beschrijft die mogelijkerwijs in de prostaat zijn origine heeft. In 
Hoofdstuk 1 wordt een overzicht gegeven van de moeizame vorderingen gedurende 
de laatste eeuw op het gebied van diagnostiek en behandeling van patiënten met 
prostatitis syndromen. Wij zijn het eens met Stamey, die de gouden standaard voor 
de diagnostiek van de verschillende vormen van prostatitis ontwikkeld heeft, dat er 
nog niet veel meer bekend is hierover dan aan het begin van deze eeuw. Met name 
diagnostiek en behandeling van niet-bacteriële prostatitis, die het grootste gedeelte 
van de patiënten omvat, is extreem moeilijk. De verschillende factoren en organis-
men die een niet-bacteriële prostatitis veroorzaken zijn verwarrend, elkaar tegen-
sprekend en slecht gedefinieerd. Dat resulteert uiteindelijk in allerlei theoriën en een 
rijke schakering van therapiën. Het lijkt alsof de meeste van deze therapiën met 
antibiotica beginnen en uiteindelijk eindigen met een goed gesprek over de aard van 
de aandoening: er kan niets gedaan worden. 
In Hoofstuk 3 hebben we de resultaten van diagnostiek en behandeling bij meer 
dan 400 patiënten met prostatitis syndromen, die poliklinisch gezien zijn, geïnventa-
riseerd. The patiënten waren midden veertigers en bij de meesten bestonden de 
klachten hooguit 6 maanden. De resultaten van de radiodiagnostiek waren teleur-
stellend en daarom kwamen we tot de conclusie dat deze beeldvormende diagnos-
tiek slechts van beperkt nut is bij de screening van patiënten met een prostatitis 
syndroom. Natuurlijk dient altijd een urinesediment verricht te worden evenals een 
urinekweek en een urine cytologisch onderzoek. Afwijkingen bij uroflowmetrie wor-
den vaak gezien en kunnen veroorzaakt worden door buiten de prostaat gelegen 
oorzaken. Omdat deze patiënten goed reageren op σ,-blokkerende medicijnen, dient 
bij de screening altijd een uroflowmetrie plaats te vinden. De resultaten van antimi-
crobiële therapie waren teleurstellend. Gelijke resultaten werden verkregen indien 
geen antibiotica werden voorgeschreven (genezing, verbetering en stabilisatie bij 
respectievelijk eenderde der gevallen). Meer dan één kuur met antibiotica heeft ook 
geen nut. 
In Hoofdstuk 4 geven we de resultaten weer van een enquête onder Nederlandse 
urologen en huisartsen betreffende diagnostiek en behandelingsresultaten van pati-
ënten met prostatitis syndromen. Uit deze studie mogen we concluderen dat de 
patiënten die een uroloog consulteren jonger zijn en meestal pijnklachten perineaal, 
aan de penis of het scrotum hebben. Een verdere evaluatie door de uroloog bestaat 
uit de 4-glazen test en een frequente toepassing van uroflowmetrie. Huisartsen 
daarentegen zien vaker oudere patiënten met mictieklachten. Daarom vragen wij 
ons af of veel van deze patiënten die door de huisartsen gezien worden niet ge-
woonweg prostatisme klachten hebben ten gevolge van een benigne prostaat hy-
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perplasie. Tevens is er een opmerkelijk verschil betreffende de veronderstelde oor-
zaak van deze klachten. Huisartsen denken dat een bacteriële infectie de veroorza-
ker is terwijl urologen een niet-bacteriële oorzaak noemen. Daarnaast is er een evi-
dent verschil in opinie betreffende een psychosomatische component van deze 
"ziekte". Mischien is er een relatie tussen de resultaten van therapie en het vermoe-
den van psychosomatiek. Huisartsen geven redelijke genezingspercentages weer en 
volgens hun speelt psychosomatiek slechts een beperkte rol. Urologen verkrijgen 
matige resultaten van hun behandeling en het ligt dan ook in de verwachting dat bij 
hen een sterke verdenking op psychosomatiek bestaat. Ofschoon een infect vaak 
niet kan worden opgespoord, bestaat de eerst keuze van therapie uit antibiotica. 
Vanwege het sterke vermoeden op psychosomatiek bij deze patiënten, hebben 
wij een studie verricht die de persoonlijkheidskenmerken bij patiënten met prostati-
tis syndromen in kaart brengt. In Hoofdstuk 5 hebben we een groep van vijftig 
patiënten met chronische prostatitis klachten vergeleken met vijftig patiënten die 
ons consulteerden met het verzoek tot een sterilisatie. Tussen beide groepen zagen 
we statistisch significante verschillen. In absolute zin waren deze verschillen echter 
slechts gering en minimaal indien deze vergeleken werden met de resultaten bij een 
groep psychiatrische patiënten. Een analyse geeft aan dat bij prostatitis patiënten 
somatisatie en depressie vaker gezien werden. Derhalve kwamen we tot de conclu-
sie dat er op grond van deze studie geen redenen bestaan om patiënten met prosta-
titis syndromen als "neurotisch" of "psychopathologisch" te bestempelen. Het is 
bovendien niet mogelijk persoonlijkheidskenmerken te benoemen die specifiek ge-
acht kunnen worden voor deze patiënten. Echter in geval van een verhoogde score 
op depressie zou het kunnen zijn dat sommige van deze patiënten, vooral wanneer 
die samengaat met pijnklachten, baat zouden kunnen hebben van antidepressiva in 
een lage dosering. 
Omdat de diagnostiek bij patiënten met prostatitis syndromen moeilijk is, dient 
men op z'n minst ernstige aandoeningen, die prostatitis-achtige klachten kunnen 
geven, uitgesloten te worden. In Hoofdstuk 6 presenteren we de resultaten van een 
retrospectieve studie bij patiënten, bij wie initieel de diagnose "prostatitis" gesteld 
was. Bij 6,3 procent van de urinemonsters werd ernstige atypie gevonden. Verdere 
evaluatie liet zien dat bij bijna de helft van deze patiënten een blaasmaligniteit ge-
vonden werd. De belangrijkste klachten bij deze patiënten waren pijn en irritatieve 
blaasklachten en een urinesediment liet altijd erytrocyturie zien. Daarom willen we 
nogmaals benadrukken dat een urinecytologisch onderzoek bij patiënten met pros-
tatitis syndromen altijd verricht dient te worden. Uit onze enquête echter kwam 
naar voren dat slechts 35% van alle urologen routinematig een urine cytologisch 
onderzoek verrichten. 
Echografie van de prostaat kan gemakkelijk gedaan worden, is niet belastend 
voor de patiënt, relatief goedkoop en eerste keuze van beeldvorming van de pros-
taat. De kwaliteit van transrectale echografie is de laatste jaren aanzienlijk verbe-
terd en een ervaren uroloog kan vrij nauwkeurig afwijkingen van de prostaat onder-
kennen. Echter bij patiënten met prostatitis syndromen zijn uiteenlopende echografi-
sche resultaten beschreven. In Hoofdstuk 7 beschrijven wij onze echografische 
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bevindingen bij patiënten met een niet-bacteriële prostatitis. Naar aanleiding van 
deze studie kwamen we tot de conclusie dat, in tegenstelling tot eerdere bevindin-
gen, een constante dilatatie van de periprostatische veneuze plexus meer uitgespro-
ken was bij de controle groep evenals een dilatatie van de vesiculae seminalis. 
Verkalkingen in de prostaat werden bij beide groepen vaak gezien. We waren ge-
woonweg niet in staat om te differentiëren tussen ziek en niet ziek. Ondertussen 
hebben we op onze afdeling een systeem voor automatische analyse van echografie 
beelden ontwikkeld. In Hoofdstuk 8 geven we de resultaten weer van de toepassing 
van dit systeem bij patiënten met een histologisch bewezen prostatitis. Eerdere 
studies hadden reeds een hoge correlatie laten zien tussen histologische bevindin-
gen en de resultaten van de localisatiestudies. Daarom namen wij aan dat, indien 
het mogelijk zou zijn om prostatitis te detecteren middels beeldanalyse technieken 
van transrectale echografie beelden, dit een grote verbetering zou betekenen voor 
de diagnostiek bij deze patiënten. Een evaluatie liet zien dat een goede sensitiviteit 
(90,6%) bereikt werd doch dat de specificiteit aanzienlijk lager was (64,2%). De 
positieve predictieve waarde voor prostatitis was 50% terwijl de negatieve predic-
tieve waarde 94,6% was. Dit betekent dat bij een aanzienlijk aantal patiënten de 
diagnose "prostatitis" ten onrechte gesteld wordt. In geval van een bewezen pros-
tatitis echter, is de voorspelling bijna altijd correct. We kwamen tot de conclusie dat 
de eerste resultaten van deze analyses zeer bemoedigend zijn. Een verbetering van 
het systeem kan leiden tot een instrument dat de uroloog kan ondersteunen bij de 
diagnostiek en behandeling van patiënten met prostatitis. 
Tenslotte bediscussiëren we in Hoofdstuk 9 de resultaten die we verkregen bij 
patiënten met prostatitis syndromen, met hoofdzakelijk mictieklachten en bewezen 
urodynamische afwijkingen, waarbij σ,-blokkerende medicatie gebruikt werd. Omdat 
veel patiënten met prostatitis syndromen eveneens een slechte mictiestraal verto-
nen, laat verder onderzoek bij deze mensen vaak outflow problemen zien. Gebruik 
van de eerdergenoemde medicatie resulteert in een relaxatie van de gladde muscu-
latuur op het niveau van de blaashals en de prostaatloge. In deze studie werd zowel 
een significante subjectieve en objectieve respons waargenomen. De resultaten van 
behandeling van deze patiënten met σ,-receptor blokkerende medicatie zijn veelbelo­
vend 

119 
DANKWOORD 
Graag wil ik iedereen die aan de totstandkoming van dit proefschrift een bijdrage 
hebben geleverd bedanken. Allereerst Professor F.M.J. Debruyne, de promotor van 
dit proefschrift, die samen met mij deze moeilijke materie geëxploreerd heeft. Wij 
hebben samen het "prostatitis syndroom" bestudeerd hetgeen geresulteerd heeft in 
enige nieuwe gezichtspunten. Maar zoals dat een ijsbergfenomeen betaamt, geldt 
ook hier dat er nog véél meer is. 
Dr. H.F.M. Karthaus bedank ik voor de mogelijkheden die hij mij binnen zijn kliniek 
geboden heeft om eveneens onderzoek te doen. Naast zijn constante en kritische 
stimulering waardeerde ik zeker net zo onze uitstekende onderlinge verstandhouding 
en prettige samenwerking. Herbert mijn oprechte dank hiervoor. 
Drs M.R. Hubregtse heeft mij in den beginne terzijde gestaan bij het traditionele 
status onderzoek. Bedankt Mark voor al je uurtjes in het archief en achter de 
computer. Je ziet, hard werken loont zo nu en dan. 
Eveneens wil ik de andere co-authers bedanken voor hun ondersteuning en 
bijdrage. De een heeft mogelijk wat meer bijgedragen dan de ander echter eenieders 
hulp was steeds welkom, zelfs onontbeerlijk om dit proefschrift te realiseren. 
Tenslotte heeft elk boekje een orginele kaft nodig en ik wil daarom dan ook Marq 
bedanken, die volgens mij hierin zeer goed geslaagd is. 
En natuurlijk mijn ouders, schoonouders, Colette en Louis. Hun belangstelling en 
bemoediging gedurende de afgelopen jaren heb ik altijd zeer kunnen waarderen. 
Last but not least heeft een promovendus af en toe stress. Bedankt Greetje voor 
je grote steun. Je bent de afgelopen jaren voor mij echt de rots in de branding 
geweest. 

121 
CURRICULUM VITAE 
Johan Jozef Maria Catharina Hubertus de la Rosette 
Geboortedatum: 25 november 1957 
Geboorteplaats: Heerlen 
Opleiding: 1977: Atheneum В te Vaals 
1985: Arts examen Geneeskunde 
1992: erkend als uroloog 
Sinds 1 januari 1993 Staflid Uroloog aan de afdeling urologie van het Academisch 
Ziekenhuis te Nijmegen, met als speciale vakgebied prostaataandoeningen (Hoofd: 
Prof.Dr. F.M.J. Debruyne). 



Stellingen behorende bij het proefschrift 
New aspects in diagnosis and treatment of prostatitis 
1 De meest frequent toegepaste therapie bij prostatitis patiënten is antibioti-
ca. Er worden echter vergelijkbare resultaten bereikt indien geen antibioti-
ca worden voorgeschreven, (dit proefschrift) 
2 Onderzoek naar buiten de prostaat gelegen oorzaken wijst vaak op 
functionele afwijkingen van de lagere urinewegen. De resultaten van de 
behandeling van deze patiënten met σ,-receptor blokkerende medicatie is 
veelbelovend, (dit proefschrift) 
3 De bij psychologische testen gevonden verschillen bij prostatitis patiënten 
ten aanzien van somatisatie en depressie kunnen verklaard worden door 
de aard van hun lichamelijke klachten, (dit proefschrift) 
4 Bij patiënten met prostatitis klachten dient cytologisch onderzoek van de 
urine altijd verricht te worden, (dit proefschrift) 
5 Ofschoon zich bij echografie van de prostaat bij patiënten met prostatitis 
klachten een heel scala aan afwijkingen presenteerd, kan hiermee de 
diagnose niet gesteld worden, (dit proefschrift). 
6 Computer analyse van transrectale echografie beelden kan de uroloog 
ondersteunen bij de interpretatie van deze prostaat afbeeldingen en 
successievelijk bij de diagnose en behandeling van prostaat aandoenin-
gen, (dit proefschrift) 
7 Huisartsen beschouwen een bacterieël infect als de meest belangrijke 
oorzaak van prostatitis terwijl urologen een niet bacteriële oorzaak 
vermoeden. Dit zou een verklaring kunnen zijn voor de hogere succesratio 
bij behandeling van deze patiënten, zoals deze gevonden wordt bij huisart-
sen, (dit proefschrift) 
8 Echografie van de nieren en een blanco buikoverzicht hebben slechts 
beperkte waarde bij de screening van patiënten met prostatitis klachten, 
(dit proefschrift) 
9 TUMT is geen afkorting voor Trans Urethrale Moerman Therapie. 
10 Als je niet kunt afvallen, kun je wel degelijk opvallen. 
11 Een peniskoker is geen beroep. 
12 De promovendus belaserd regelmatig patiënten. Zij vinden dat helemaal 
niet erg. 
13 Dertien is geen ongeluksgetal. 
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